| For: | Brunt EM, Tiniakos DG. Histopathology of nonalcoholic fatty liver disease. World J Gastroenterol 2010; 16(42): 5286-5296 [PMID: 21072891 DOI: 10.3748/wjg.v16.i42.5286] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i42/5286.htm |
| Number | Citing Articles |
| 1 |
Karen Smayra, Shahid Miangul, Nathanael Yap, Ao Shi, Fatma Abdulsalam, Maamoun Adra, Hayato Nakanishi, Jake Ball, Tara A. Betts, Christian A. Than, Aneeta Parthipun. Technical Success, Sample Adequacy, and Complications of Pediatric Transjugular Liver Biopsy: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 2023; 68(10) doi: 10.1007/s10620-023-08071-4
|
| 2 |
Shinhiti Morita, Dalísio De Santi Neto, Flávio Hiroshi Ananias Morita, Nina Kimie Morita, Suzana Margareth Ajeje Lobo. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery. Obesity Surgery 2015; 25(12) doi: 10.1007/s11695-015-1696-5
|
| 3 |
Shadae R. Foster, Lowell L. Dilworth, Rory K. Thompson, Ruby L. Alexander-Lindo, Felix O. Omoruyi. Effects of combined inositol hexakisphosphate and inositol supplement on antioxidant activity and metabolic enzymes in the liver of streptozotocin-induced type 2 diabetic rats. Chemico-Biological Interactions 2017; 275 doi: 10.1016/j.cbi.2017.07.024
|
| 4 |
Berend J. van Welzen, Tania Mudrikova, Ayman El Idrissi, Andy I. M. Hoepelman, Joop E. Arends. A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?. Infectious Diseases and Therapy 2019; 8(1) doi: 10.1007/s40121-018-0229-7
|
| 5 |
Miren García-Cortés, Juan Pedro Toro-Ortiz, Alberto García-García. Deciphering the liver enigma: distinguishing drug-induced liver injury and metabolic dysfunction-associated steatotic liver disease—a comprehensive narrative review. Exploration of Digestive Diseases 2023; doi: 10.37349/edd.2023.00034
|
| 6 |
Gerald Y. Minuk, Venera Iliant, Nancy Zhou, Kelly D. Kaita, Stephen G. Wong, David Peretz, Julia Uhanova. Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitis. Liver International 2018; 38(6) doi: 10.1111/liv.13644
|
| 7 |
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of Diabetes. Clinical Gastroenterology 2018; doi: 10.1007/978-3-319-75856-5_21
|
| 8 |
Neti Jayanti, Rozzana Said, Suhaidah Jofrry, Chee-Yan Choo. Mechanistic pathway of herbs in the amelioration of NAFLD: A systematic review. World Academy of Sciences Journal 2024; 6(4) doi: 10.3892/wasj.2024.245
|
| 9 |
Yang Zhang, Gerd Bobe, Cristobal L Miranda, Malcolm B Lowry, Victor L Hsu, Christiane V Lohr, Carmen P Wong, Donald B Jump, Matthew M Robinson, Thomas J Sharpton, Claudia S Maier, Jan F Stevens, Adrian F Gombart. Tetrahydroxanthohumol, a xanthohumol derivative, attenuates high-fat diet-induced hepatic steatosis by antagonizing PPARγ. eLife 2021; 10 doi: 10.7554/eLife.66398
|
| 10 |
James C. Barton, J. Clayborn Barton, Ronald T. Acton. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02763-x
|
| 11 |
Yusuf Yilmaz, Zobair M. Younossi. Obesity-Associated Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2014; 18(1) doi: 10.1016/j.cld.2013.09.018
|
| 12 |
M. Bekaert, X. Verhelst, A. Geerts, B. Lapauw, P. Calders. Association of recently described adipokines with liver histology in biopsy‐proven non‐alcoholic fatty liver disease: a systematic review. Obesity Reviews 2016; 17(1) doi: 10.1111/obr.12333
|
| 13 |
Fan-Jhen Dai, Wei-Hsuan Hsu, Jan-Jeng Huang, She-Ching Wu. Effect of pigeon pea (Cajanus cajan L.) on high-fat diet-induced hypercholesterolemia in hamsters. Food and Chemical Toxicology 2013; 53 doi: 10.1016/j.fct.2012.12.029
|
| 14 |
Saana Palomurto, Kirsi A Virtanen, Vesa Kärjä, Ursula Schwab, Dorota Kaminska, Pirjo Käkelä, Jussi Pihlajamäki, Ville Männistö. Metabolic Dysfunction-associated Steatotic Liver Disease Alters Fatty Acid Profiles in the Liver and Adipose Tissue. The Journal of Clinical Endocrinology & Metabolism 2025; 111(1) doi: 10.1210/clinem/dgaf346
|
| 15 |
Marco Arrese, Juan Pablo Arab, Juan Pablo Arancibia, Roberto Candia, Arnoldo Riquelme, Francisco Barrera. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. 2012; doi: 10.1016/B978-0-12-385083-6.00023-1
|
| 16 |
Linjie Qiu, Bin Kong, Tiantian Kong, Huan Wang. Recent advances in liver‐on‐chips: Design, fabrication, and applications. Smart Medicine 2023; 2(1) doi: 10.1002/SMMD.20220010
|
| 17 |
Anthony J. Demetris, Marta I. Minervini, Michael A. Nalesnik, Erin Rubin, Parmjeet Randhawa, Eizaburo Sasatomi. Textbook of Organ Transplantation. 2014; doi: 10.1002/9781118873434.ch82
|
| 18 |
Jain Kumar, Jeffery Teckman. Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology. Children 2015; 2(3) doi: 10.3390/children2030358
|
| 19 |
Ilham Yahya Alimansyah, Mahmud Dwi Sulistiyo, Tjokorda Agung Budi Wirayuda. Segmentation of Hepatic Steatosis in a Histopathological Image Using U-Net-based Architecture. 2025 International Conference on Data Science and Its Applications (ICoDSA) 2025; doi: 10.1109/ICoDSA67155.2025.11157107
|
| 20 |
Chun‐Seok Cho, Hwan‐Woo Park, Allison Ho, Ian A. Semple, Boyoung Kim, Insook Jang, Haeli Park, Shannon Reilly, Alan R. Saltiel, Jun Hee Lee. Lipotoxicity induces hepatic protein inclusions through TANK binding kinase 1–mediated p62/sequestosome 1 phosphorylation. Hepatology 2018; 68(4) doi: 10.1002/hep.29742
|
| 21 |
Xavier Loyer, Valérie Paradis, Carole Hénique, Anne-Clémence Vion, Nathalie Colnot, Coralie L Guerin, Cécile Devue, Sissi On, Jérémy Scetbun, Mélissa Romain, Jean-Louis Paul, Marc E Rothenberg, Patrick Marcellin, François Durand, Pierre Bedossa, Carina Prip-Buus, Eric Baugé, Bart Staels, Chantal M Boulanger, Alain Tedgui, Pierre-Emmanuel Rautou. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Gut 2016; 65(11) doi: 10.1136/gutjnl-2014-308883
|
| 22 |
Yuji Oe, Mieko Ko, Tomofumi Fushima, Emiko Sato, S. Ananth Karumanchi, Hiroshi Sato, Junichi Sugawara, Sadayoshi Ito, Nobuyuki Takahashi. Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-017-18260-7
|
| 23 |
Anna Alisi, Ariel E. Feldstein, Alberto Villani, Massimiliano Raponi, Valerio Nobili. Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nature Reviews Gastroenterology & Hepatology 2012; 9(3) doi: 10.1038/nrgastro.2011.273
|
| 24 |
Yusuf Yilmaz, Yasar Colak, Ramazan Kurt, Ebubekir Senates, Fatih Eren. Linking Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: From Bedside to Bench and Back. Tumori Journal 2013; 99(1) doi: 10.1177/030089161309900102
|
| 25 |
Munechika Enjoji, Kenichiro Yasutake, Motoyuki Kohjima, Makoto Nakamuta. Alcohol, Nutrition, and Health Consequences. 2013; doi: 10.1007/978-1-62703-047-2_40
|
| 26 |
Mara Lúcia de Campos, Marina Bento de Castro, Artur Domingos Campos, Maria Fernanda Fernandes, Jéssica Leiras Mota Conegundes, Matheus Nehrer Rodrigues, Fernanda Lins Brandão Mügge, Aristóbolo Mendes da Silva, Céphora Maria Sabarense, Maria Christina Marques Nogueira Castañon, Ana Eliza Andreazzi, Elita Scio. Antiobesity, hepatoprotective and anti-hyperglycemic effects of a pharmaceutical formulation containing Cecropia pachystachya Trécul in mice fed with a hypercaloric diet. Journal of Ethnopharmacology 2021; 280 doi: 10.1016/j.jep.2021.114418
|
| 27 |
Roderich E. Schwarz, Jordan D. Berlin, Heinz J. Lenz, Bernard Nordlinger, Laura Rubbia‐Brandt, Michael A. Choti. Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement. HPB 2013; 15(2) doi: 10.1111/j.1477-2574.2012.00558.x
|
| 28 |
Aman Sharma. Lipid droplets associated perilipins protein insights into finding a therapeutic target approach to cure non-alcoholic fatty liver disease (NAFLD). Future Journal of Pharmaceutical Sciences 2022; 8(1) doi: 10.1186/s43094-021-00395-0
|
| 29 |
Hamed Zamanian, Ahmad Shalbaf. Grading of steatosis, fibrosis, lobular inflammation, and ballooning from liver pathology images using pre‐trained convolutional neural networks. International Journal of Imaging Systems and Technology 2023; 33(6) doi: 10.1002/ima.22936
|
| 30 |
Sandrine Barbois, Catherine Arvieux, Vincent Leroy, Fabian Reche, Nathalie Stürm, Anne-Laure Borel. Benefit–risk of intraoperative liver biopsy during bariatric surgery: review and perspectives. Surgery for Obesity and Related Diseases 2017; 13(10) doi: 10.1016/j.soard.2017.07.032
|
| 31 |
Mariana Catta-Preta, Leonardo Souza Mendonca, Julio Fraulob-Aquino, Marcia Barbosa Aguila, Carlos Alberto Mandarim-de-Lacerda. A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies. Virchows Archiv 2011; 459(5) doi: 10.1007/s00428-011-1147-1
|
| 32 |
Dinali H. Fernando, Josephine M. Forbes, Peter W. Angus, Chandana B. Herath. Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products. International Journal of Molecular Sciences 2019; 20(20) doi: 10.3390/ijms20205037
|
| 33 |
Brett McGettigan, Rachel McMahan, David Orlicky, Matthew Burchill, Thomas Danhorn, Prashanth Francis, Lin Ling Cheng, Lucy Golden‐Mason, Claudia V. Jakubzick, Hugo R. Rosen. Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages. Hepatology 2019; 70(1) doi: 10.1002/hep.30401
|
| 34 |
Marjolein H. Tiebosch, Golnar Karimian, Han Moshage. Studies on Hepatic Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice 2015; doi: 10.1007/978-3-319-15539-5_4
|
| 35 |
José S. Morgado, Ivo F. Machado, Anabela P. Rolo, Carlos M. Palmeira. Restoring Mitochondrial Homeostasis: Therapeutic Strategies for Metabolic Dysfunction-Associated Fatty Liver Disease. International Journal of Molecular Sciences 2026; 27(6) doi: 10.3390/ijms27062599
|
| 36 |
Vatche G. Agopian, Fady M. Kaldas, Johnny C. Hong, Meredith Whittaker, Curtis Holt, Abbas Rana, Ali Zarrinpar, Henrik Petrowsky, Douglas Farmer, Hasan Yersiz, Victor Xia, Jonathan R. Hiatt, Ronald W. Busuttil. Liver Transplantation for Nonalcoholic Steatohepatitis. Annals of Surgery 2012; 256(4) doi: 10.1097/SLA.0b013e31826b4b7e
|
| 37 |
Maria Teresa Borrello, Maria Rita Emma, Angela Listi, Marion Rubis, Sergiu Coslet, Giuseppa Augello, Antonella Cusimano, Daniela Cabibi, Rossana Porcasi, Lydia Giannitrapani, Maurizio Soresi, Gianni Pantuso, Karen Blyth, Giuseppe Montalto, Christopher Pin, Melchiorre Cervello, Juan Iovanna. NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response. The FASEB Journal 2021; 35(3) doi: 10.1096/fj.202002413RR
|
| 38 |
Azam Asilian Bidgoli, Shahryar Rahnamayan, Taher Dehkharghanian, Abtin Riasatian, Hamid R. Tizhoosh. Evolutionary Computation in Action: Hyperdimensional Deep Embedding Spaces of Gigapixel Pathology Images. IEEE Transactions on Evolutionary Computation 2023; 27(1) doi: 10.1109/TEVC.2022.3178299
|
| 39 |
Ajay Kumar Jain, Abhineet Sharma, Sumit Arora, Keith Blomenkamp, Ik Chan Jun, Robert Luong, David John Westrich, Aayush Mittal, Paula M. Buchanan, Miguel A. Guzman, John Long, Brent A. Neuschwander‐Tetri, Jeffery Teckman. Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid–Treated Animals Receiving Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition 2017; 41(2) doi: 10.1177/0148607116661838
|
| 40 |
Ajay Kumar Jain, Carel W. le Roux, Puneet Puri, Ali Tavakkoli, Nana Gletsu‐Miller, Blandine Laferrère, Richard Kellermayer, John K. DiBaise, Robert G. Martindale, Bruce M. Wolfe. Proceedings of the 2017 ASPEN Research Workshop—Gastric Bypass: Role of the Gut. Journal of Parenteral and Enteral Nutrition 2018; 42(2) doi: 10.1002/jpen.1121
|
| 41 |
Lindsei K. Sarna, Yaw L. Siow, Karmin O. The CBS/CSE system: a potential therapeutic target in NAFLD?. Canadian Journal of Physiology and Pharmacology 2015; 93(1) doi: 10.1139/cjpp-2014-0394
|
| 42 |
Vahide Betül CANITEZ, İbrahim GÜNEY, Edip ERKUŞ. Metabolik Sendromlu Olmayan Hastalarda Non-Alkolik Yağlı Karaciğer Hastalığı. Batı Karadeniz Tıp Dergisi 2021; 5(2) doi: 10.29058/mjwbs.811398
|
| 43 |
J. A. Kramer, J. Grindley, A. M. Crowell, L. Makaron, R. Kohli, M. Kirby, K. G. Mansfield, L. M. Wachtman. The Common Marmoset as a Model for the Study of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Veterinary Pathology 2015; 52(2) doi: 10.1177/0300985814537839
|
| 44 |
Michele d’Angelo, Vanessa Castelli, Maria Grazia Tupone, Mariano Catanesi, Andrea Antonosante, Reyes Dominguez-Benot, Rodolfo Ippoliti, Anna Maria Cimini, Elisabetta Benedetti. Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs. International Journal of Molecular Sciences 2019; 20(21) doi: 10.3390/ijms20215422
|
| 45 |
Fabio Piscaglia, Bernardo Stefanini, Eleonora Terzi, Mariarosaria Marseglia, Vito Cantisani. Liver Fat Quantification: When do We Need It?. Ultraschall in der Medizin - European Journal of Ultrasound 2023; 44(02) doi: 10.1055/a-2015-5693
|
| 46 |
Mari Lahelma, Sami Qadri, Noora Ahlholm, Kimmo Porthan, Maija Ruuth, Anne Juuti, Matej Orešič, Tuulia Hyötyläinen, Katariina Öörni, Hannele Yki-Järvinen. The human liver lipidome is significantly related to the lipid composition and aggregation susceptibility of low-density lipoprotein (LDL) particles. Atherosclerosis 2022; 363 doi: 10.1016/j.atherosclerosis.2022.11.018
|
| 47 |
Helena S. Leitão, Sabrina Doblas, Gaspard d’Assignies, Philippe Garteiser, Jean-Luc Daire, Valérie Paradis, Carlos F. G. C. Geraldes, Valérie Vilgrain, Bernard E. Van Beers. Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis. European Radiology 2013; 23(2) doi: 10.1007/s00330-012-2626-8
|
| 48 |
Pathik Parikh, Jatin Patel, Meghraj Ingle, Prabha Sawant. Serum ferritin levels predict histological severity in patients with nonalcoholic fatty liver disease in India. Indian Journal of Gastroenterology 2015; 34(3) doi: 10.1007/s12664-015-0572-5
|
| 49 |
Claire Mancia, Véronique Loustaud-Ratti, Paul Carrier, Florian Naudet, Eric Bellissant, François Labrousse, Nicolas Pichon. Controlled Attenuation Parameter and Liver Stiffness Measurements for Steatosis Assessment in the Liver Transplant of Brain Dead Donors. Transplantation 2015; 99(8) doi: 10.1097/TP.0000000000000652
|
| 50 |
Ana C. TUYAMA, Charissa Y. CHANG. Non‐alcoholic fatty liver disease. Journal of Diabetes 2012; 4(3) doi: 10.1111/j.1753-0407.2012.00204.x
|
| 51 |
Hidekatsu KURODA, Tamami ABE, Yudai FUJIWARA, Tomoaki NAGASAWA, Yasuhiro TAKIKAWA. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease. Choonpa Igaku 2023; 50(3) doi: 10.3179/jjmu.JJMU.R.219
|
| 52 |
Margeyi Mehta, Jigish Shah, Urvish Joshi. Understanding Insulin Resistance in NAFLD: A Systematic Review and Meta-Analysis Focused on HOMA-IR in South Asians. Cureus 2024; doi: 10.7759/cureus.70768
|
| 53 |
Enrico Magosso, Mukhtar Alam Ansari, Yogheswaran Gopalan, Ibrahim Lutfi Shuaib, Jia-Woei Wong, Nurzalina Abdul Karim Khan, Mohamed Rizal Abu Bakar, Bee-Hong Ng, Kah-Hay Yuen. Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. Nutrition Journal 2013; 12(1) doi: 10.1186/1475-2891-12-166
|
| 54 |
Geoffrey C. Farrell, Arthur J. McCullough, Christopher P. Day. Non‐Alcoholic Fatty Liver Disease. 2013; doi: 10.1002/9781118556153.ch1
|
| 55 |
Elizabeth M. Brunt, David E. Kleiner, Danielle H. Carpenter, Mary Rinella, Stephen A. Harrison, Rohit Loomba, Zobair Younossi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal. NAFLD: Reporting Histologic Findings in Clinical Practice. Hepatology 2021; 73(5) doi: 10.1002/hep.31599
|
| 56 |
Myriam Moretto, Carlos Kupski, Vinicius Duval da Silva, Alexandre V. Padoin, Cláudio C. Mottin. Effect of Bariatric Surgery on Liver Fibrosis. Obesity Surgery 2012; 22(7) doi: 10.1007/s11695-011-0559-y
|
| 57 |
Vittoria Cammisotto, Emanuele Valeriani, Pasquale Pignatelli, Francesco Violi. Nicotinamide Adenine Dinucleotide Phosphate Oxidases and Metabolic Dysfunction-Associated Steatotic Liver Disease. Antioxidants 2025; 14(1) doi: 10.3390/antiox14010083
|
| 58 |
Daniella Braz Parente. Imaging methods in the assessment of nonalcoholic fatty liver disease. Radiologia Brasileira 2020; 53(2) doi: 10.1590/0100-3984.2020.53.2e3
|
| 59 |
Yasuyuki Shigematsu, Hiroaki Kanda, Yu Takahashi, Kengo Takeuchi, Kentaro Inamura. Relationships between tumor CD147 expression, tumor-infiltrating lymphocytes, and oncostatin M in hepatocellular carcinoma. Virchows Archiv 2025; 487(1) doi: 10.1007/s00428-024-03939-w
|
| 60 |
Yunqiu Xia, Qing Li, Weizhen Zhong, Jing Dong, Zhulin Wang, Chunbo Wang. L-carnitine ameliorated fatty liver in high-calorie diet/STZ-induced type 2 diabetic mice by improving mitochondrial function. Diabetology & Metabolic Syndrome 2011; 3(1) doi: 10.1186/1758-5996-3-31
|
| 61 |
Everton Cazzo, José Carlos Pareja, Elinton Adami Chaim. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Medical Journal 2017; 135(3) doi: 10.1590/1516-3180.2016.0306311216
|
| 62 |
Anna Alisi, Guido Carpino, Valerio Nobili. Paediatric nonalcoholic fatty liver disease. Current Opinion in Gastroenterology 2013; 29(3) doi: 10.1097/MOG.0b013e32835ff95e
|
| 63 |
Dario F. De Jesus, Tomohiko Kimura, Manoj K. Gupta, Rohit N. Kulkarni. NREP contributes to development of NAFLD by regulating one-carbon metabolism in primary human hepatocytes. Cell Chemical Biology 2023; 30(9) doi: 10.1016/j.chembiol.2023.06.001
|
| 64 |
Pierre-Marie Lavrut, Olivier Guillaud, Jérôme Dumortier, Elisabeth Mintz, Virginie Brun, Sophie Heissat, Eduardo Couchonnal Bedoya, Alain Lachaux, Muriel Bost, Valerie Hervieu. Histological features of liver disease development in the Atp7b−/− mouse: a model of Wilson’s disease. Journal of Clinical Pathology 2025; 78(1) doi: 10.1136/jcp-2023-209190
|
| 65 |
Saptarshi Bhattacharyya, Ming-Lung Yu, Phumelele Yvonne Siphepho, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Shu-Chi Wang. Retrospective analysis of steatosis effect on antiviral response and hepatocellular carcinoma risk in chronic hepatitis C. Antiviral Research 2025; 240 doi: 10.1016/j.antiviral.2025.106203
|
| 66 |
Dina G. Tiniakos, Quentin M. Anstee, Alastair D. Burt. Macsween's Pathology of the Liver. 2018; doi: 10.1016/B978-0-7020-6697-9.00005-4
|
| 67 |
Najia Sharmin, Huajun Tang, Chandra Jinata, Ningbo Chen, Bingfeng Li, Nikki Pui Yue Lee, Yitian Tong, Kenneth K. Y. Wong. 1725-nm HOPE for segmentation-enabled quantitative photoacoustic microscopy of intrahepatic lipids. Photonics Research 2025; 13(7) doi: 10.1364/PRJ.553103
|
| 68 |
Daniella Braz Parente, Jaime Araújo Oliveira Neto, Pedro Emmanuel Alvarenga Americano Brasil, Fernando Fernandes Paiva, José Pedro Rodrigues Ravani, Marilia Brito Gomes, Valeria Lanzoni, Carlos Frederico Ferreira Campos, Lilian Machado‐Silva, Renata Mello Perez, Rosana Souza Rodrigues. Preperitoneal fat as a non‐invasive marker of increased risk of severe non‐alcoholic fatty liver disease in patients with type 2 diabetes. Journal of Gastroenterology and Hepatology 2018; 33(2) doi: 10.1111/jgh.13903
|
| 69 |
Sichao WANG, Weixia SUN, Yiping CHENG, Lei WANG, Shizhan MA, Fei JING, Xiujuan ZHANG, Xinli ZHOU. Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity. Minerva Endocrinology 2025; 50(1) doi: 10.23736/S2724-6507.21.03424-6
|
| 70 |
Marcus Alvarez, Jihane N. Benhammou, Nicholas Darci-Maher, Samuel W. French, Steven B. Han, Janet S. Sinsheimer, Vatche G. Agopian, Joseph R. Pisegna, Päivi Pajukanta. Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival. Genome Medicine 2022; 14(1) doi: 10.1186/s13073-022-01055-5
|
| 71 |
Akiko Suzuki, Keisuke Kakisaka, Yuji Suzuki, Ting Wang, Yasuhiro Takikawa. c-Jun N-terminal kinase-mediated Rubicon expression enhances hepatocyte lipoapoptosis and promotes hepatocyte ballooning. World Journal of Gastroenterology 2016; 22(28): 6509-6519 doi: 10.3748/wjg.v22.i28.6509
|
| 72 |
Violaine Capitan, Jean-Michel Petit, Serge Aho, Pierre-Henri Lefevre, Sylvain Favelier, Romaric Loffroy, Patrick Hillon, Denis Krausé, Jean-Pierre Cercueil, Boris Guiu. Macroscopic heterogeneity of liver fat: an MR-based study in type-2 diabetic patients. European Radiology 2012; 22(10) doi: 10.1007/s00330-012-2468-4
|
| 73 |
Gashaw Hassen, Abhishek Singh, Gizeshwork Belete, Nidhi Jain, Ivonne De la Hoz, Genesis P Camacho-Leon, Nitsuh K Dargie, Keila G Carrera, Tadesse Alemu, Sharan Jhaveri, Nebiyou Solomon. Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. Cureus 2022; doi: 10.7759/cureus.25495
|
| 74 |
Daniel Andrade Tinoco de Souza, Daniella Braz Parente, Antonio Luis Eiras de Araújo, Koenraad J. Mortelé. Modern Imaging Evaluation of the Liver. Magnetic Resonance Imaging Clinics of North America 2013; 21(2) doi: 10.1016/j.mric.2013.01.001
|
| 75 |
Stepan Melnyk, Soheila Korourian, Joseph Levy, Oleksandra Pavliv, Teresa Evans, Reza Hakkak. Effects of Obesity on Pro-Oxidative Conditions and DNA Damage in Liver of DMBA-Induced Mammary Carcinogenesis Models. Metabolites 2017; 7(2) doi: 10.3390/metabo7020026
|
| 76 |
Michael Taulo Lund, Marianne Kristensen, Merethe Hansen, Louise Tveskov, Andrea Karen Floyd, Mikael Støckel, Ben Vainer, Steen Seier Poulsen, Jørn Wulff Helge, Clara Prats, Flemming Dela. Hepatic mitochondrial oxidative phosphorylation is normal in obese patients with and without type 2 diabetes. The Journal of Physiology 2016; 594(15) doi: 10.1113/JP272105
|
| 77 |
Evgin Goceri, Zarine K. Shah, Rick Layman, Xia Jiang, Metin N. Gurcan. Quantification of liver fat: A comprehensive review. Computers in Biology and Medicine 2016; 71 doi: 10.1016/j.compbiomed.2016.02.013
|
| 78 |
Mohamed Bejaoui, Mohamed Amine Zaouali, Emma Folch-Puy, Eirini Pantazi, Fawzia Bardag-Gorce, Teresa Carbonell, Joan Oliva, Antoni Rimola, Hassen Ben Abdennebi, Joan Roselló-Catafau. Bortezomib enhances fatty liver preservation in Institut George Lopez-1 solution through adenosine monophosphate activated protein kinase and Akt/mTOR pathways. Journal of Pharmacy and Pharmacology 2014; 66(1) doi: 10.1111/jphp.12154
|
| 79 |
Julien Rogier, Stéphanie Roullet, François Cornélis, Matthieu Biais, Alice Quinart, Philippe Revel, Paulette Bioulac‐Sage, Brigitte Le Bail. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver‐to‐spleen attenuation ratio. Liver Transplantation 2015; 21(5) doi: 10.1002/lt.24105
|
| 80 |
Elina Petäjä, Hannele Yki-Järvinen. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review. International Journal of Molecular Sciences 2016; 17(5) doi: 10.3390/ijms17050633
|
| 81 |
R Christopher Harmon, Dina G Tiniakos, Curtis K Argo. Inflammation in nonalcoholic steatohepatitis. Expert Review of Gastroenterology & Hepatology 2011; 5(2) doi: 10.1586/egh.11.21
|
| 82 |
Manuela G. Neuman, Samuel W. French, Samir Zakhari, Stephen Malnick, Helmut K. Seitz, Lawrence B Cohen, Mikko Salaspuro, Andreea Voinea-Griffin, Andrei Barasch, Irina A. Kirpich, Paul G. Thomes, Laura W. Schrum, Terrence M. Donohue, Kusum K. Kharbanda, Marcus Cruz, Mihai Opris. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Experimental and Molecular Pathology 2017; 102(1) doi: 10.1016/j.yexmp.2017.01.003
|
| 83 |
Manuela França, João Mota Louro. Imaging of the Liver and Intra-hepatic Biliary Tract. Medical Radiology 2021; doi: 10.1007/978-3-030-38983-3_13
|
| 84 |
Nadia S. Orona, Francisco Astort, Guillermo A. Maglione, Sebastian A. Ferraro, Maximiliano Martin, Celina Morales, Patricia M. Mandalunis, Fernando Brites, Deborah R. Tasat. Hazardous effects of urban air particulate matter acute exposure on lung and extrapulmonary organs in mice. Ecotoxicology and Environmental Safety 2020; 190 doi: 10.1016/j.ecoenv.2019.110120
|
| 85 |
Linda Vanessa Márquez-Quiroga, Irina Cardoso-Lezama, Brisa Rodope Alarcón-Sánchez, Pamela Gaitán-González, Osiris Germán Idelfonso-García, Eduardo E. Vargas-Pozada, Carolina Piña-Vázquez, Erika Ramos-Tovar, Saúl Villa-Treviño, Jaime Arellanes-Robledo, Pablo Muriel. The progression of metabolic dysfunction-associated steatotic liver disease toward hepatocellular carcinoma in an efficient rat model. Biochemical Pharmacology 2025; 242 doi: 10.1016/j.bcp.2025.117369
|
| 86 |
Mara Lúcia de Campos, Maria Fernanda Fernandes, Marina B. de Castro, Artur D. Campos, Paula P. Pires, Rafaela de O. Andrade, Isadora M. de Oliveira, Aristóbolo M. da Silva, Céphora Maria Sabarense, Maria Christina M.N. Castañon, Ana Eliza Andreazzi, Elita Scio. A pharmaceutical formulation containing Cecropia pachystachya alleviates metabolic alterations in a hypercaloric diet obesity model in Swiss mice. Biocatalysis and Agricultural Biotechnology 2022; 43 doi: 10.1016/j.bcab.2022.102376
|
| 87 |
G. Invernizzi, S. Modina, D. Corbani, V. Bronzo, L.F. Pisani, J.M. Caputo, A. Agazzi, V. Dell’Orto, G. Savoini. Hepatic and subcutaneous adipose tissue variations in transition dairy goats fed saturated or unsaturated fat supplemented diets. Small Ruminant Research 2016; 144 doi: 10.1016/j.smallrumres.2016.09.009
|
| 88 |
Jake P. Mann, Rita De Vito, Antonella Mosca, Anna Alisi, Matthew J. Armstrong, Massimiliano Raponi, Ulrich Baumann, Valerio Nobili. Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease. Hepatology 2016; 63(3) doi: 10.1002/hep.28374
|
| 89 |
Antonella Mosca, Silvio Veraldi, Andrea Dellostrologo, Mariateresa Sanseviero, Valerio Nobili. Pediatric Hepatology and Liver Transplantation. 2019; doi: 10.1007/978-3-319-96400-3_17
|
| 90 |
Yasuyuki Shigematsu, Kazuhito Tanaka, Gulanbar Amori, Hiroaki Kanda, Yu Takahashi, Yutaka Takazawa, Kengo Takeuchi, Kentaro Inamura. Potential involvement of oncostatin M in the immunosuppressive tumor immune microenvironment in hepatocellular carcinoma with vessels encapsulating tumor clusters. Hepatology Research 2024; 54(4) doi: 10.1111/hepr.13988
|
| 91 |
Paola Fierabracci, Anna Tamberi, Ferruccio Santini. Minimally Invasive Bariatric and Metabolic Surgery. 2015; doi: 10.1007/978-3-319-15356-8_4
|
| 92 |
Seul Ki Han, Soon Koo Baik, Moon Young Kim. Non-alcoholic fatty liver disease: Definition and subtypes. Clinical and Molecular Hepatology 2023; 29(Suppl) doi: 10.3350/cmh.2022.0424
|
| 93 |
Yasuyuki Shigematsu, Gulanbar Amori, Kazuhito Tanaka, Keiichiro Kitahama, Hiroaki Kanda, Yu Takahashi, Yutaka Takazawa, Kengo Takeuchi, Kentaro Inamura. MHC class I loss is associated with biliary/progenitor cell features and “cold” tumor-immune microenvironment in hepatocellular carcinoma. Virchows Archiv 2023; 483(2) doi: 10.1007/s00428-023-03568-9
|
| 94 |
Viviane Brandão Amorim, Daniella Braz Parente, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Amanda Almeida Miranda, Cláudia Cravo Moreira, Flávia Ferreira Fernandes, Carlos Frederico Ferreira Campos, Nathalie Carvalho Leite, Renata de Mello Perez, Rosana Souza Rodrigues. Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?. World Journal of Hepatology 2020; 12(9): 661-671 doi: 10.4254/wjh.v12.i9.661
|
| 95 |
Kyriakos Dimitriadis, Panagiotis Iliakis, Angeliki Vakka, Nikolaos Pyrpyris, Anna Pitsillidi, Panagiotis Tsioufis, Christos Fragkoulis, Dagmara Hering, Joachim Weil, Anastasios Kollias, Dimitris Konstantinidis, Konstantinos Tsioufis. Effects of Sympathetic Denervation in Metabolism Regulation: A Novel Approach for the Treatment of MASLD?. Cardiology in Review 2025; doi: 10.1097/CRD.0000000000000850
|
| 96 |
Frances L Byrne, Kyle L Hoehn. Subclassification of fatty liver by its pathogenesis: cIEFing is believing. The Journal of Pathology 2016; 239(1) doi: 10.1002/path.4702
|
| 97 |
Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim. Non-alcoholic fatty liver disease: the pathologist’s perspective. Clinical and Molecular Hepatology 2023; 29(Suppl) doi: 10.3350/cmh.2022.0329
|
| 98 |
Yasuyo Urasaki, Ronald R Fiscus, Thuc T Le. Molecular classification of fatty liver by high‐throughput profiling of protein post‐translational modifications. The Journal of Pathology 2016; 238(5) doi: 10.1002/path.4685
|
| 99 |
Nicholas Szary, R. Rector, Grace Uptergrove, Suzanne Ridenhour, Shivendra Shukla, John Thyfault, Lauren Koch, Steven Britton, Jamal Ibdah. High Intrinsic Aerobic Capacity Protects against Ethanol-Induced Hepatic Injury and Metabolic Dysfunction: Study Using High Capacity Runner Rat Model. Biomolecules 2015; 5(4) doi: 10.3390/biom5043295
|
| 100 |
Caezaan Keshvani, Jonathan Kopel, Hemant Goyal. Obeticholic Acid—A Pharmacological and Clinical Review. Future Pharmacology 2023; 3(1) doi: 10.3390/futurepharmacol3010017
|
| 101 |
|
| 102 |
Toshio Maeda, Satomi Miki, Naoaki Morihara, Yoshiyuki Kagawa. Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance . Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7636
|
| 103 |
Trevor W Reichman, George Therapondos, Maria-Stella Serrano, John Seal, Rachel Evers-Meltzer, Humberto Bohorquez, Ari Cohen, Ian Carmody, Emily Ahmed, David Bruce, George E Loss. “Weighing the risk”: Obesity and outcomes following liver transplantation. World Journal of Hepatology 2015; 7(11): 1484-1493 doi: 10.4254/wjh.v7.i11.1484
|
| 104 |
Ville T. Männistö, Marko Simonen, Jenni Hyysalo, Pasi Soininen, Antti J. Kangas, Dorota Kaminska, Ananda K. Matte, Sari Venesmaa, Pirjo Käkelä, Vesa Kärjä, Johanna Arola, Helena Gylling, Henna Cederberg, Johanna Kuusisto, Markku Laakso, Hannele Yki‐Järvinen, Mika Ala‐Korpela, Jussi Pihlajamäki. Ketone body production is differentially altered in steatosis and non‐alcoholic steatohepatitis in obese humans. Liver International 2015; 35(7) doi: 10.1111/liv.12769
|
| 105 |
Y. Yilmaz. Review article: non‐alcoholic fatty liver disease and osteoporosis – clinical and molecular crosstalk. Alimentary Pharmacology & Therapeutics 2012; 36(4) doi: 10.1111/j.1365-2036.2012.05196.x
|
| 106 |
Yi Tan, Weiguo Lao, Linda Xiao, Zhenzhong Wang, Wei Xiao, Mohamed A. Kamal, J. Paul Seale, Xianqin Qu. Managing the Combination of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome with Chinese Herbal Extracts in High-Fat-Diet Fed Rats. Evidence-Based Complementary and Alternative Medicine 2013; 2013 doi: 10.1155/2013/306738
|
| 107 |
Zhenxing Hao, Xuexue Song, Juan Han, Changqing Wang, Yanying Ma. A deep learning framework for quantification of hepatic steatosis in whole-slide images by tile-level scoring and screening. Biomedical Physics & Engineering Express 2026; 12(3) doi: 10.1088/2057-1976/ae7a7b
|
| 108 |
Masato Yoneda, Hideki Fujii, Yoshio Sumida, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Kento Imajo, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshikazu Yoshikawa, Takeshi Okanoue. Platelet count for predicting fibrosis in nonalcoholic fatty liver disease. Journal of Gastroenterology 2011; 46(11) doi: 10.1007/s00535-011-0436-4
|
| 109 |
You-Jin Choi, Yeonsoo Kim, Seonghwan Hwang. Role of Neutrophils in the Development of Steatotic Liver Disease. Seminars in Liver Disease 2024; 44(03) doi: 10.1055/s-0044-1789207
|
| 110 |
Saumya Jayakumar, Stephen A. Harrison, Rohit Loomba. Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease. Current Hepatology Reports 2016; 15(2) doi: 10.1007/s11901-016-0296-8
|
| 111 |
Marion Imbault, Alex Faccinetto, Bruno-Félix Osmanski, Antoine Tissier, Thomas Deffieux, Jean-Luc Gennisson, Valérie Vilgrain, Mickaël Tanter. Robust sound speed estimation for ultrasound-based hepatic steatosis assessment. Physics in Medicine and Biology 2017; 62(9) doi: 10.1088/1361-6560/aa6226
|
| 112 |
Yoshihiro Kamada, Maaya Akita, Yuri Takeda, Shin Yamada, Hideki Fujii, Yoshiyuki Sawai, Yoshinori Doi, Hitomi Asazawa, Kotarosumitomo Nakayama, Kayo Mizutani, Hironobu Fujii, Takayuki Yakushijin, Masanori Miyazaki, Hisao Ezaki, Naoki Hiramatsu, Yuichi Yoshida, Shinichi Kiso, Yasuharu Imai, Norifumi Kawada, Tetsuo Takehara, Eiji Miyoshi, Silvia C. Sookoian. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis. PLoS ONE 2013; 8(6) doi: 10.1371/journal.pone.0066328
|
| 113 |
Fani-Niki Varra, Michail Varras, Viktoria-Konstantina Varra, Panagiotis Theodosis-Nobelos. Mechanisms Linking Obesity with Non-Alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Diseases (CVDs)—The Role of Oxidative Stress. Current Issues in Molecular Biology 2025; 47(9) doi: 10.3390/cimb47090766
|
| 114 |
Nishant Parmar, Muslim Atiq, Lee Austin, Ross A. Miller, Thomas Smyrk, Kabir Ahmed. Glycogenic Hepatopathy: Thinking Outside the Box. Case Reports in Gastroenterology 2015; 9(2) doi: 10.1159/000437048
|
| 115 |
Taiyu Shang, Tianyi Jiang, Xiaowen Cui, Yufei Pan, Xiaofan Feng, Liwei Dong, Hongyang Wang. Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases. Genes & Diseases 2024; 11(4) doi: 10.1016/j.gendis.2023.03.035
|
| 116 |
Geoffrey C. Farrell, Vincent Wai-Sun Wong, Shiv Chitturi. NAFLD in Asia—as common and important as in the West. Nature Reviews Gastroenterology & Hepatology 2013; 10(5) doi: 10.1038/nrgastro.2013.34
|
| 117 |
Carlotta Hoffmann, Philipp A. Gerber, Claudia Cavelti-Weder, Louisa Licht, Reham Kotb, Rania Al Dweik, Michele Cherfane, Stefan R. Bornstein, Nikolaos Perakakis. Liver, NAFLD and COVID-19. Hormone and Metabolic Research 2022; 54(08) doi: 10.1055/a-1834-9008
|
| 118 |
Claus Hellerbrand, Jörn M. Schattenberg, Philipp Peterburs, Anja Lechner, Reto Brignoli. The potential of silymarin for the treatment of hepatic disorders. Clinical Phytoscience 2017; 2(1) doi: 10.1186/s40816-016-0019-2
|
| 119 |
Yosuke Kawano, Masahiro Tanabe, Fumi Kameda, Mayumi Higashi, Kenichiro Ihara, Masaya Tanabe, Atsuo Inoue, Taiga Kobayashi, Takaaki Ueda, Katsuyoshi Ito. Lobar hepatic steatosis: Association with portal flow hemodynamics evaluated by multiphasic dynamic contrast-enhanced CT. European Journal of Radiology 2023; 160 doi: 10.1016/j.ejrad.2023.110688
|
| 120 |
Can Jiang, Yuriko Saiki, Shuto Hirota, Kosei Iwata, Xinyue Wang, Yutaka Ito, Keigo Murakami, Takehiro Imura, Jun Inoue, Atsushi Masamune, Akiyoshi Hirayama, Masafumi Goto, Toru Furukawa. Ablation of Dual-Specificity Phosphatase 6 Protects against Nonalcoholic Fatty Liver Disease via Cytochrome P450 4A and Mitogen-Activated Protein Kinase. The American Journal of Pathology 2023; 193(12) doi: 10.1016/j.ajpath.2023.09.003
|
| 121 |
Eva Morán‐Salvador, Marta López‐Parra, Verónica García‐Alonso, Esther Titos, Marcos Martínez‐Clemente, Ana González‐Périz, Cristina López‐Vicario, Yaacov Barak, Vicente Arroyo, Joan Clària. Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockouts. The FASEB Journal 2011; 25(8) doi: 10.1096/fj.10-173716
|
| 122 |
Kameliya Bratoeva, Silviya Nikolova, Albena Merdzhanova, George St. Stoyanov, Eleonora Dimitrova, Javor Kashlov, Nikolay Conev, Mariya Radanova. Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic Syndrome. Metabolic Syndrome and Related Disorders 2018; 16(7) doi: 10.1089/met.2017.0162
|
| 123 |
Azam Asilian Bidgoli, Shahryar Rahnamayan, Taher Dehkharghanian, Ali Grami, H.R. Tizhoosh. Bias reduction in representation of histopathology images using deep feature selection. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-24317-z
|
| 124 |
Maria Luger, Renate Kruschitz, Christian Kienbacher, Stefan Traussnigg, Felix B. Langer, Karin Schindler, Tanja Würger, Friedrich Wrba, Michael Trauner, Gerhard Prager, Bernhard Ludvik. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency. Obesity Surgery 2016; 26(10) doi: 10.1007/s11695-016-2123-2
|
| 125 |
Anitha Saravanakumar, Cassandra A. Tierney, Wen He, Rohitash Jamwal, Benjamin Barlock, Xin Bush, Jillian G. Johnson, David A Rodrigues, Fatemeh Akhlaghi. Transcriptomic and Proteomics Analysis of a Lipid-Loaded HepaRG Model for Steatosis Reveals Altered Regulation in Lipid and Xenobiotic Metabolism. Current Drug Metabolism 2025; 26(5) doi: 10.2174/0113892002381234250727004847
|
| 126 |
Gustavo Macedo HADDAD, Martinho Antonio GESTIC, Murillo Pimentel UTRINI, Felipe David Mendonça CHAIM, Elinton Adami CHAIM, Everton CAZZO. DIAGNOSTIC ACCURACY OF THE NON-INVASIVE MARKERS NFLS, NI-NASH-DS, AND FIB-4 FOR ASSESSMENT OF DIFFERENT ASPECTS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN INDIVIDUALS WITH OBESITY: CROSS-SECTIONAL STUDY. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612023-050
|
| 127 |
Dejun Teng, Zhaochuan Li, Zhaohui Peng, Shuai Ma, Fusheng Wang. Efficient and Accurate Spatial Queries Using Lossy Compressed 3D Geometry Data. IEEE Transactions on Knowledge and Data Engineering 2025; 37(5) doi: 10.1109/TKDE.2025.3539729
|
| 128 |
Heloisa Aparecida Barbosa Silva Pereira, Aline Salgado Dionizio, Mileni Silva Fernandes, Tamara Teodoro Araujo, Tânia Mary Cestari, Camila Peres Buzalaf, Flávia Godoy Iano, Marília Afonso Rabelo Buzalaf, Michael Bader. Fluoride Intensifies Hypercaloric Diet-Induced ER Oxidative Stress and Alters Lipid Metabolism. PLOS ONE 2016; 11(6) doi: 10.1371/journal.pone.0158121
|
| 129 |
Sven M. Francque, W. J. Kwanten, D. van der Graaff. Portal Hypertension in NASH: Is It Different from Other Aetiologies?. Current Hepatology Reports 2019; 18(2) doi: 10.1007/s11901-019-00459-z
|
| 130 |
Gene P. Ables. Update on Ppar and Nonalcoholic Fatty Liver Disease. PPAR Research 2012; 2012 doi: 10.1155/2012/912351
|
| 131 |
Suzan Schwertheim, Julia Kälsch, Holger Jastrow, Christoph Matthias Schaefer, Sarah Theurer, Saskia Ting, Ali Canbay, Heiner Wedemeyer, Kurt Werner Schmid, Hideo Andreas Baba. Characterization of two types of intranuclear hepatocellular inclusions in NAFLD. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71646-y
|
| 132 |
Laura Draijer, Marc Benninga, Bart Koot. Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. Expert Review of Gastroenterology & Hepatology 2019; 13(5) doi: 10.1080/17474124.2019.1595589
|
| 133 |
Paulina Głuszyńska, Dorota Lemancewicz, Janusz Bogdan Dzięcioł, Hady Razak Hady. Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review. Journal of Clinical Medicine 2021; 10(24) doi: 10.3390/jcm10245721
|
| 134 |
Y. Yilmaz. Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?. Alimentary Pharmacology & Therapeutics 2012; 36(9) doi: 10.1111/apt.12046
|
| 135 |
Hidekatsu Kuroda, Tamami Abe, Yudai Fujiwara, Tomoaki Nagasawa, Yasuhiro Takikawa. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease. Journal of Medical Ultrasonics 2021; 48(4) doi: 10.1007/s10396-021-01123-0
|
| 136 |
Thing-Fong Tzeng, Shorong-Shii Liou, I.-Min Liu. 6-Gingerol mitigates nutritional steatohepatitis through regulating key genes related to oxidative stress, inflammation and fibrogenesis. RSC Adv. 2014; 4(106) doi: 10.1039/C4RA12030B
|
| 137 |
Haritya Shah, Murthy N Guddati. Towards linking histological changes to liver viscoelasticity: a hybrid analytical-computational micromechanics approach. Physics in Medicine & Biology 2025; 70(4) doi: 10.1088/1361-6560/adaad3
|
| 138 |
Jesse D. Riordan, Joseph H. Nadeau. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mammalian Genome 2014; 25(9-10) doi: 10.1007/s00335-014-9521-3
|
| 139 |
Adviti Naik, Rok Košir, Damjana Rozman. Genomic aspects of NAFLD pathogenesis. Genomics 2013; 102(2) doi: 10.1016/j.ygeno.2013.03.007
|
| 140 |
Hua Li, Wonbeak Yoo, Hye-Mi Park, Soo-Youn Lim, Dong-Ha Shin, Seokho Kim, Ho-Yong Park, Tae-Sook Jeong. Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model. International Journal of Molecular Sciences 2019; 20(9) doi: 10.3390/ijms20092325
|
| 141 |
Kutay Kirdok, Özge Yogurtcu, Tahir Buran, Elmas Kasap. Can the FIB-4 score predict the severity of acute pancreatitis in NAFLD?. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00313-y
|
| 142 |
Mohammad Alomari, Mamoon Ur Rashid, Pravallika Chadalavada, Jonathan Ragheb, Hammad Zafar, Zoilo Karim Suarez, Shrouq Khazaaleh, Adalberto Jose Gonzalez, Fernando J Castro. Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes. World Journal of Hepatology 2023; 15(4): 477-496 doi: 10.4254/wjh.v15.i4.477
|
| 143 |
Joanna Podgorska, Agnieszka Anysz-Grodzicka, Andrzej Cieszanowski. State-of-the-art MR Imaging of Fat-containing Focal Lesions of the Liver. Current Medical Imaging Formerly Current Medical Imaging Reviews 2019; 15(5) doi: 10.2174/1573405614666171218154838
|
| 144 |
Mariane Róvero Costa, Jéssica Leite Garcia, Carol Cristina Vágula de Almeida Silva, Artur Junio Togneri Ferron, Fabiane Valentini Francisqueti-Ferron, Fabiana Kurokawa Hasimoto, Cristina Schmitt Gregolin, Dijon Henrique Salomé de Campos, Cleverton Roberto de Andrade, Ana Lúcia dos Anjos Ferreira, Camila Renata Corrêa, Fernando Moreto. Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats. Antioxidants 2019; 8(8) doi: 10.3390/antiox8080276
|
| 145 |
Stephen D. H. Malnick, Pavel Alin, Marina Somin, Manuela G. Neuman. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different. International Journal of Molecular Sciences 2022; 23(24) doi: 10.3390/ijms232416226
|
| 146 |
Maria Magdalena Quetglas-Llabrés, Margalida Monserrat-Mesquida, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza, Josep A. Tur, Antoni Sureda. Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized Trial. Antioxidants 2024; 13(7) doi: 10.3390/antiox13070754
|
| 147 |
Chelsea Hearn, Betty J. Ellington, Roberta Jones. The Role of the Nurse Practitioner in the Management of Nonalcoholic Fatty Liver Disease. Gastroenterology Nursing 2018; 41(5) doi: 10.1097/SGA.0000000000000394
|
| 148 |
Kristina-Ana Klaric, Jacqueline Louise Parai, Charis Anthea Kepron, Alfredo Eugene Walker, Christopher Mark Milroy. Postmortem survey of haemoglobin A1c, non-alcoholic steatohepatitis and liver fibrosis within a general population. Journal of Clinical Pathology 2023; 76(9) doi: 10.1136/jclinpath-2021-207998
|
| 149 |
Mawia Khairalseed, Katherine Brown, Kevin J. Parker, Kenneth Hoyt. Real-time H-scan ultrasound imaging using a Verasonics research scanner. Ultrasonics 2019; 94 doi: 10.1016/j.ultras.2018.12.010
|
| 150 |
Alexandra Collin de l’Hortet, Kazuki Takeishi, Jorge Guzman-Lepe, Kazutoyo Morita, Abhinav Achreja, Branimir Popovic, Yang Wang, Kan Handa, Anjali Mittal, Noah Meurs, Ziwen Zhu, Frank Weinberg, Michael Salomon, Ira J. Fox, Chu-Xia Deng, Deepak Nagrath, Alejandro Soto-Gutierrez. Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism. Cell Metabolism 2019; 30(2) doi: 10.1016/j.cmet.2019.06.017
|
| 151 |
Nina Bastati, Diana Feier, Andreas Wibmer, Stefan Traussnigg, Csilla Balassy, Dietmar Tamandl, Henrik Einspieler, Friedrich Wrba, Michael Trauner, Christian Herold, Ahmed Ba-Ssalamah. Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid–enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study. Radiology 2014; 271(3) doi: 10.1148/radiol.14131890
|
| 152 |
Yoshihisa Takahashi, Toshio Fukusato. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World Journal of Gastroenterology 2014; 20(42): 15539-15548 doi: 10.3748/wjg.v20.i42.15539
|
| 153 |
Dahae Lee, Kiwon Jung, Jaemin Lee, Hyo Jin Kang, Ju Young Lee, Jason Kim, Dayeon Ham, Jaejin Cho, Dae-Woon Eom, Ki Sung Kang. Role of 11β-hydroxysteroid dehydrogenase type 1 inhibition in the antiobesity effect of J2H-1702 on adipocytes and a high-fat diet-induced NASH model. European Journal of Pharmacology 2025; 989 doi: 10.1016/j.ejphar.2025.177272
|
| 154 |
Ivana Cerović, Dušan Mladenović, Rada Ješić, Tamara Naumović, Miloš Branković, Danijela Vučević, Vuk Aleksić, Tatjana Radosavljević. Alcoholic liver disease/nonalcoholic fatty liver disease index. European Journal of Gastroenterology & Hepatology 2013; 25(8) doi: 10.1097/MEG.0b013e32835f0786
|
| 155 |
Aline Dionizio, Heloisa Aparecida Barbosa Silva Pereira, Tamara Teodoro Araujo, Isabela Tomazini Sabino-Arias, Mileni Silva Fernandes, Karina Aparecida Oliveira, Fabielle Sales Raymundo, Tânia Mary Cestari, Fernando Neves Nogueira, Rui Albuquerque Carvalho, Marília Afonso Rabelo Buzalaf. Effect of Duration of Exposure to Fluoride and Type of Diet on Lipid Parameters and De Novo Lipogenesis. Biological Trace Element Research 2019; 190(1) doi: 10.1007/s12011-018-1542-4
|
| 156 |
Dieter Furthner, Daniel Weghuber, Christopher Dalus, Andreas Lukas, Hannah N. Stundner-Ladenhauf, Harald Mangge, Thomas Pixner. Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps. Hormone Research in Paediatrics 2022; 95(2) doi: 10.1159/000518595
|
| 157 |
Manman Li, Xueting Niu, Rui Zhang, Yuxiao Xing, Quanwei Zhang, Haitian Ma. Asiaticoside alleviates metabolic associated fatty liver disease via PI3K/AKT/mTOR signaling pathway. Toxicology and Applied Pharmacology 2026; 514 doi: 10.1016/j.taap.2026.117925
|
| 158 |
Manorama Swain, Preetam Nath, Prasant Kumar Parida, Jimmy Narayan, Pradeep Kumar Padhi, Girish Kumar Pati, Ayaskanta Singh, Bijay Misra, Debasis Misra, Sanjib Kumar Kar, Manas Kumar Panigrahi, Chudamani Meher, Omprakash Agrawal, Niranjan Rout, Kaumudee Pattnaik, Pallavi Bhuyan, Pramila Kumari Mishra, Shivaram Prasad Singh. Biochemical Profile of Nonalcoholic Fatty Liver Disease Patients in Eastern India with Histopathological Correlation. Indian Journal of Clinical Biochemistry 2017; 32(3) doi: 10.1007/s12291-016-0612-7
|
| 159 |
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation. 2021; doi: 10.1016/B978-0-7020-7584-1.00007-3
|
| 160 |
Olga H. Orasan, Mihaela Iancu, Madalina Sava, Aniela Saplontai‐Pop, Angela Cozma, Simina Tarmure Sarlea, Corneliu Lungoci, Marius‐Ionut Ungureanu, Vasile Negrean, Dorel Sampelean, Dan Lucian Dumitrascu. Non‐invasive assessment of liver fibrosis in chronic viral hepatitis. European Journal of Clinical Investigation 2015; 45(12) doi: 10.1111/eci.12543
|
| 161 |
Garyfallia Kapravelou, Rosario Martínez, Ana M. Andrade, Elena Nebot, Daniel Camiletti-Moirón, Virginia A. Aparicio, Maria Lopez-Jurado, Pilar Aranda, Francisco Arrebola, Eduardo Fernandez-Segura, Giovanna Bermano, Marie Goua, Milagros Galisteo, Jesus M. Porres. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats. Applied Physiology, Nutrition, and Metabolism 2015; 40(12) doi: 10.1139/apnm-2015-0141
|
| 162 |
Bin Teng, Chen Huang, Chuan-Li Cheng, Anjaneyulu Udduttula, Xiang-Fang Yu, Chang Liu, Jian Li, Zhen-Yu Yao, Jing Long, Li-Fu Miao, Chao Zou, Jun Chu, Jian V. Zhang, Pei-Gen Ren. Newly identified peptide hormone inhibits intestinal fat absorption and improves NAFLD through its receptor GPRC6A. Journal of Hepatology 2020; 73(2) doi: 10.1016/j.jhep.2020.02.026
|
| 163 |
Daniella Braz Parente, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Lilian Machado-Silva, Fatima Aparecida Ferreira Figueiredo, Valeria Lanzoni, Carlos Frederico Ferreira Campos, Pedro Emmanuel Alvarenga Americano do Brasil, Marilia de Brito Gomes, Renata de Mello Perez, Rosana Souza Rodrigues, Erica Villa. Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients. PLOS ONE 2015; 10(5) doi: 10.1371/journal.pone.0125653
|
| 164 |
Amirhossein Sahebkar, Elena Sancho, David Abelló, Jordi Camps, Jorge Joven. Novel circulating biomarkers for non‐alcoholic fatty liver disease: A systematic review. Journal of Cellular Physiology 2018; 233(2) doi: 10.1002/jcp.25779
|
| 165 |
Vettickattuparambil George Giby, Thekkuttuparambil Ananthanarayanan Ajith. Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. World Journal of Hepatology 2014; 6(8): 570-579 doi: 10.4254/wjh.v6.i8.570
|
| 166 |
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation. 2016; doi: 10.1016/B978-0-7020-5548-5.00007-4
|
| 167 |
Stephanie Coulon, Sven Francque, Isabelle Colle, An Verrijken, Bram Blomme, Femke Heindryckx, Steffi De Munter, Janne Prawitt, Sandrine Caron, Bart Staels, Hans Van Vlierberghe, Luc Van Gaal, Anja Geerts. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease. Cytokine 2012; 59(2) doi: 10.1016/j.cyto.2012.05.001
|
| 168 |
Tomasz Dziodzio, Matthias Biebl, Robert Öllinger, Johann Pratschke, Christian Denecke. The Role of Bariatric Surgery in Abdominal Organ Transplantation—the Next Big Challenge?. Obesity Surgery 2017; 27(10) doi: 10.1007/s11695-017-2854-8
|
| 169 |
Ana Andres-Hernando, David J. Orlicky, Gabriela E. Garcia, Esteban C. Loetz, Richard Montoya, Vijay Kumar, Devin P. Effinger, Masanari Kuwabara, So Young Bae, Laura Lorenzo-Rebenaque, Elena Fauste, Richard L. Bell, Nicholas Grahame, Suthat Liangpunsakul, Hahn Kim, Sundeep Dugar, Paul Maffuid, Takahiko Nakagawa, Michael F. Wempe, J. Mark Petrash, Dean R. Tolan, Sondra T. Bland, Richard J. Johnson, Miguel A. Lanaspa. Identification of a common ketohexokinase-dependent link driving alcohol intake and alcohol-associated liver disease in mice. Nature Metabolism 2025; 7(11) doi: 10.1038/s42255-025-01402-x
|
| 170 |
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt, Alastair D. Burt. MacSween's Pathology of the Liver. 2024; doi: 10.1016/B978-0-7020-8228-3.00005-3
|
| 171 |
Martha Eunice de Bessa, Vivian Tomasco Andrade, Gabriele Moreira Guimarães, Ana Flávia Lawall Werneck Cerqueira, Carolina Carvalho Ramos Viana, Marianna Miranda Furtado, Renata de Freitas Mendes, Mirian Pereira Rodarte, Anderson S. Sant’Ana, Maria José Valenzuela Bell, Maria Christina Marques Nogueira Castañon, Maria Silvana Alves, Elisabeth Neumann, Elita Scio. Carbohydrate-Rich Extract from Pereskia aculeata Leaves: In Vitro Prebiotic-Related Properties and Metabolic Effects in an Experimental Model of Obesity. Plant Foods for Human Nutrition 2026; 81(2) doi: 10.1007/s11130-026-01486-0
|
| 172 |
Yusuf Yilmaz. Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome?. World Journal of Hepatology 2012; 4(12): 332-334 doi: 10.4254/wjh.v4.i12.332
|
| 173 |
Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Manuela Abbate, Sofía Montemayor, Catalina M. Mascaró, Miguel Casares, Silvia Tejada, Itziar Abete, Maria Angeles Zulet, Josep A. Tur, J. Alfredo Martínez, Antoni Sureda. Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants 2020; 9(8) doi: 10.3390/antiox9080759
|
| 174 |
Haoyu Tian, Shuairan Zhang, Ying Liu, Yifan Wu, Dianbao Zhang. Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges. International Journal of Molecular Sciences 2023; 24(5) doi: 10.3390/ijms24054583
|
| 175 |
Andrew J. Muir. Understanding the Complexities of Cirrhosis. Clinical Therapeutics 2015; 37(8) doi: 10.1016/j.clinthera.2015.05.507
|
| 176 |
R. W. H. Hui, W.‐K. Seto, K.‐S. Cheung, L.‐Y. Mak, K. S. H. Liu, J. Fung, D. K.‐H. Wong, C.‐L. Lai, M.‐F. Yuen. Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case‐control study. Journal of Viral Hepatitis 2018; 25(1) doi: 10.1111/jvh.12766
|
| 177 |
Munechika Enjoji, Kenichiro Yasutake, Motoyuki Kohjima, Makoto Nakamuta. Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol. International Journal of Hepatology 2012; 2012 doi: 10.1155/2012/925807
|
| 178 |
Hideki Kumagai, Koji Yokoyama, Kimito Katsuyama, Shoji Hara, Hiroaki Yamamoto, Takanori Yamagata, Nobuyuki Taniguchi, Norio Hirota, Kouichi Itoh. A New Method for Measuring the Speed of Sound in Rat Liver ex Vivo Using an Ultrasound System: Correlation of Sound Speed with Fat Deposition. Ultrasound in Medicine & Biology 2014; 40(10) doi: 10.1016/j.ultrasmedbio.2014.03.019
|
| 179 |
Matthew C. Sinton, David C. Hay, Amanda J. Drake. Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0702-5
|
| 180 |
Renao Yan, Qiming He, Yiqing Liu, Peng Ye, Lianghui Zhu, Shanshan Shi, Jizhou Gou, Yonghong He, Tian Guan, Guangde Zhou. Unpaired virtual histological staining using prior-guided generative adversarial networks. Computerized Medical Imaging and Graphics 2023; 105 doi: 10.1016/j.compmedimag.2023.102185
|
| 181 |
Claudia Della Corte, Anna Alisi, Alessia Saccari, Rita De Vito, Andrea Vania, Valerio Nobili. Nonalcoholic Fatty Liver in Children and Adolescents: An Overview. Journal of Adolescent Health 2012; 51(4) doi: 10.1016/j.jadohealth.2012.01.010
|
| 182 |
Wei Zhong, Yantao Zhao, Xinguo Sun, Zhenyuan Song, Craig J. McClain, Zhanxiang Zhou, Marcia B. Aguila. Dietary Zinc Deficiency Exaggerates Ethanol-Induced Liver Injury in Mice: Involvement of Intrahepatic and Extrahepatic Factors. PLoS ONE 2013; 8(10) doi: 10.1371/journal.pone.0076522
|
| 183 |
Yueming Tang, Lijuan Zhang, Christopher B. Forsyth, Maliha Shaikh, Shiwen Song, Ali Keshavarzian. The Role of miR‐212 andiNOSin Alcohol‐Induced Intestinal Barrier Dysfunction and Steatohepatitis. Alcoholism: Clinical and Experimental Research 2015; 39(9) doi: 10.1111/acer.12813
|
| 184 |
Michael Doulberis, Stergios A. Polyzos, Apostolis Papaefthymiou, Panagiotis Katsinelos, Christos Kiosses, Jannis Kountouras. Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents. Expert Opinion on Pharmacotherapy 2020; 21(3) doi: 10.1080/14656566.2019.1702967
|
| 185 |
D. van der Graaff, W.J. Kwanten, S.M. Francque. The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis. Medical Hypotheses 2019; 122 doi: 10.1016/j.mehy.2018.11.014
|
| 186 |
Elizabeth M Brunt. Non-alcoholic fatty liver disease: what's new under the microscope?. Gut 2011; 60(8) doi: 10.1136/gut.2010.218214
|
| 187 |
Si-Yuan Pan, Qing Yu, Yi Zhang, Xiao-Yan Wang, Nan Sun, Zhi-Ling Yu, Kam-Ming Ko. Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity. Lipids in Health and Disease 2012; 11(1) doi: 10.1186/1476-511X-11-120
|
| 188 |
Noa Mashav, Oren Shibolet. Liver Metabolism and Fatty Liver Disease. Oxidative Stress and Disease 2014; 20144564 doi: 10.1201/b17315-3
|
| 189 |
Saechol Park, Jeongwoo Choi, Kyeonga Kim, Donghyun Oh, Junghee Yoon, Mincheol Choi. Point shear wave elastography of the liver in healthy adult cats. American Journal of Veterinary Research 2021; 82(4) doi: 10.2460/ajvr.82.4.286
|
| 190 |
Carmelo García‐Monzón, Javier Vargas‐Castrillón, José Luís Porrero, María Teresa Alonso, Oscar Bonachía, María José Castillo, Alberto Marcos, Esther Quirós, Beatriz Ramos, Carlos Sánchez‐Cabezudo, Sol Villar, Alicia Sáez, Javier Rodríguez de Cía, Elvira del Pozo, Lorena Vega‐Piris, Susana Soto‐Fernández, Oreste Lo Iacono, María Eugenia Miquilena‐Colina. Prevalence and risk factors for biopsy‐proven non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones. Liver International 2015; 35(8) doi: 10.1111/liv.12813
|
| 191 |
Raj Vuppalanchi, Mohammad S. Siddiqui, Mark L. Van Natta, Erin Hallinan, Danielle Brandman, Kris Kowdley, Brent A. Neuschwander‐Tetri, Rohit Loomba, Srinivas Dasarathy, Manal Abdelmalek, Edward Doo, James A. Tonascia, David E. Kleiner, Arun J. Sanyal, Naga Chalasani. Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology 2018; 67(1) doi: 10.1002/hep.29489
|
| 192 |
Michael J. J. Chu, Anthony R. J. Phillips, Alexander W. G. Hosking, Julia R. MacDonald, Adam S. J. R. Bartlett, Anthony J. R. Hickey, Carlos M. Rodriguez-Ortigosa. Hepatic Mitochondrial Function Analysis Using Needle Liver Biopsy Samples. PLoS ONE 2013; 8(10) doi: 10.1371/journal.pone.0079097
|
| 193 |
Mawia Khairalseed, Girdhari Rijal, Kenneth Hoyt. Spatial comparison between the H -scan format for classification of ultrasound scatterers and histology - Preliminary results using an animal model of breast cancer. 2020 IEEE International Ultrasonics Symposium (IUS) 2020; doi: 10.1109/IUS46767.2020.9251789
|
| 194 |
Helena S. Leitão, Cláudia Paulino, Dírcea Rodrigues, Sónia I. Gonçalves, Cristina Marques, Manuela Carvalheiro, Carlos F.G.C. Geraldes, Filipe Caseiro-Alves. MR Fat Fraction Mapping. Academic Radiology 2013; 20(8) doi: 10.1016/j.acra.2013.05.004
|
| 195 |
Carmelo García‐Monzón, Oreste Lo Iacono, Javier Crespo, Manuel Romero‐Gómez, Javier García‐Samaniego, Miguel Fernández‐Bermejo, Agustín Domínguez‐Díez, Javier Rodríguez de Cía, Alicia Sáez, José Luís Porrero, Javier Vargas‐Castrillón, Enrique Chávez‐Jiménez, Susana Soto‐Fernández, Ainhoa Díaz, Rocío Gallego‐Durán, Antonio Madejón, María Eugenia Miquilena‐Colina. Increased soluble CD36 is linked to advanced steatosis in nonalcoholic fatty liver disease. European Journal of Clinical Investigation 2014; 44(1) doi: 10.1111/eci.12192
|
| 196 |
Caroline S. Stokes, Frank Lammert, Marcin Krawczyk. Short-term Dietary Interventions for the Management of Nonalcoholic Fatty Liver. Current Medicinal Chemistry 2019; 26(19) doi: 10.2174/0929867324666170508144409
|
| 197 |
Monjur Ahmed. Non-alcoholic fatty liver disease in 2015. World Journal of Hepatology 2015; 7(11): 1450-1459 doi: 10.4254/wjh.v7.i11.1450
|
| 198 |
Jason Ostenson, Bruce M. Damon, E. Brian Welch. MR fingerprinting with simultaneous T1, T2, and fat signal fraction estimation with integrated B0 correction reduces bias in water T1 and T2 estimates. Magnetic Resonance Imaging 2019; 60 doi: 10.1016/j.mri.2019.03.017
|
| 199 |
Paula Toro, Daniela S. Allende. Practical Liver Pathology. Practical Anatomic Pathology 2025; doi: 10.1007/978-3-031-97506-6_13
|
| 200 |
Zoltan Pataky, Laurence Genton, Laurent Spahr, Vladimir Lazarevic, Sylvain Terraz, Nadia Gaïa, Laura Rubbia-Brandt, Alain Golay, Jacques Schrenzel, Claude Pichard. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study. Digestive Diseases and Sciences 2016; 61(9) doi: 10.1007/s10620-016-4179-1
|
| 201 |
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher, Amedeo Lonardo. Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Review of Gastroenterology & Hepatology 2018; 12(4) doi: 10.1080/17474124.2018.1415756
|
| 202 |
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061 doi: 10.1007/978-981-10-8684-7_11
|
| 203 |
Hunain Aslam, Fouzia Oza, Khalid Ahmed, Jonathan Kopel, Mark M. Aloysius, Aman Ali, Dushyant Singh Dahiya, Muhammad Aziz, Abhilash Perisetti, Hemant Goyal. The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature Review. International Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24043487
|
| 204 |
S. Berardis, E. Sokal. Pediatric non-alcoholic fatty liver disease: an increasing public health issue. European Journal of Pediatrics 2014; 173(2) doi: 10.1007/s00431-013-2157-6
|
| 205 |
Jie Yan, Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuoyu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker‐Kellogg, Peter T. C. So, Hanry Yu. Development of a classification model for non‐alcoholic steatohepatitis (NASH) using confocal Raman micro‐spectroscopy. Journal of Biophotonics 2017; 10(12) doi: 10.1002/jbio.201600303
|
| 206 |
Hazem M. El-Ashmawy, Azza M. Ahmed. Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes. European Journal of Gastroenterology & Hepatology 2019; 31(7) doi: 10.1097/MEG.0000000000001354
|
| 207 |
Christoph Jüngst, Thomas Berg, Jun Cheng, Richard M. Green, Jidong Jia, Andrew L. Mason, Frank Lammert. Intrahepatic cholestasis in common chronic liver diseases. European Journal of Clinical Investigation 2013; 43(10) doi: 10.1111/eci.12128
|
| 208 |
Jonas Roberto Velasco-Chong, Oscar Herrera-Calderón, Juan Pedro Rojas-Armas, Renán Dilton Hañari-Quispe, Linder Figueroa-Salvador, Gilmar Peña-Rojas, Vidalina Andía-Ayme, Ricardo Ángel Yuli-Posadas, Andres F. Yepes-Perez, Cristian Aguilar. TOCOSH FLOUR (Solanum tuberosum L.): A Toxicological Assessment of Traditional Peruvian Fermented Potatoes. Foods 2020; 9(6) doi: 10.3390/foods9060719
|
| 209 |
Willy Theel, Bianca M. Boxma‐de Klerk, Femme Dirksmeier‐Harinck, Elisabeth F. C. van Rossum, Danny A. Kanhai, Jan Apers, Bas M. van Dalen, Robert J. de Knegt, Adriaan G. Holleboom, Maarten E. Tushuizen, Diederick E. Grobbee, Janneke Wiebolt, Manuel Castro Cabezas. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques. Obesity Reviews 2022; 23(8) doi: 10.1111/obr.13481
|
| 210 |
Xu Li, Xiaolin Guo, Huifan Ji, Ge Yu, Pujun Gao. Gallstones in Patients with Chronic Liver Diseases. BioMed Research International 2017; 2017 doi: 10.1155/2017/9749802
|
| 211 |
Maria Apostolopoulou, Ruth Gordillo, Chrysi Koliaki, Sofia Gancheva, Tomas Jelenik, Elisabetta De Filippo, Christian Herder, Daniel Markgraf, Frank Jankowiak, Irene Esposito, Matthias Schlensak, Philipp E. Scherer, Michael Roden. Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis. Diabetes Care 2018; 41(6) doi: 10.2337/dc17-1318
|
| 212 |
Oana Irina Gavril, Lidia Iuliana Arhire, Ovidiu Mitu, Radu Sebastian Gavril, Alexandra Mastaleru, Madalina Ioana Zota, Maria-Magdalena Leon-Constantin, Teodor Vasilcu, Laura Mihalache, Florin Mitu. Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. Internal Medicine 2019; 16(1) doi: 10.2478/inmed-2019-0052
|
| 213 |
Hideki Kumagai, Kazuto Kobayashi, Sachiko Yoshida, Koji Yokoyama, Norio Hirota, Takanori Yamagata. Use of Ultrasound Microscopy for Ex Vivo Analysis of Acoustic Impedance in Mouse Liver with Steatohepatitis. Acoustics 2020; 3(1) doi: 10.3390/acoustics3010002
|
| 214 |
Brittany E. Wichman, Jamie Nilson, Srinivas Govindan, Alan Chen, Aditya Jain, Varsha Arun, Juana Derdoy, Joseph Krebs, Ajay K. Jain. Beyond lipids: Novel mechanisms for parenteral nutrition–associated liver disease. Nutrition in Clinical Practice 2022; 37(2) doi: 10.1002/ncp.10830
|
| 215 |
Kun Young Kim, Ji Soo Song, Stephan Kannengiesser, Young Min Han. Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area. La radiologia medica 2015; 120(12) doi: 10.1007/s11547-015-0545-x
|
| 216 |
Shruti Kare, Asmita Hamand. KNOWLEDGE, ATTITUDE AND PRACTICE OF GENERIC MEDICINES AMONG DENTAL GRADUATES AND POSTGRADUATE STUDENTS OF NORTH MAHARASHTRA REGION.. BULLETIN OF STOMATOLOGY AND MAXILLOFACIAL SURGERY 2025; doi: 10.58240/1829006X-2025.21.4-323
|
| 217 |
Raghu Rai Sharma, Love Sharma, Haroon Rashid, Aalim Maqsood Bhat, Divya Gupta, Sheikh Abdullah Tasduq. Co-treatment of trigonelline and everolimus synergistically prevented chronic steatohepatitis induced by fast food diet and thioacetamide in a novel murine nonalcoholic steatohepatitis model. Indian Journal of Pharmacology 2025; 57(4) doi: 10.4103/ijp.ijp_323_23
|
| 218 |
Stephanie Coulon, Vanessa Legry, Femke Heindryckx, Christophe Van Steenkiste, Christophe Casteleyn, Kim Olievier, Louis Libbrecht, Peter Carmeliet, Bart Jonckx, Jean-Marie Stassen, Hans Van Vlierberghe, Isabelle Leclercq, Isabelle Colle, Anja Geerts. Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. Hepatology 2013; 57(5) doi: 10.1002/hep.26219
|
| 219 |
K Shubham, L Vinay, P K Vinod. Systems-level organization of non-alcoholic fatty liver disease progression network. Molecular BioSystems 2017; 13(9) doi: 10.1039/C7MB00013H
|
| 220 |
Victor de Lédinghen, Julien Vergniol, Juliette Foucher, Wassil Merrouche, Brigitte le Bail. Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver International 2012; 32(6) doi: 10.1111/j.1478-3231.2012.02820.x
|
| 221 |
Nutan Sharma, Lakhwinder Singh, Aditya Sharma, Ajay Kumar, Dinesh Mahajan. NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors. Pharmacological Research 2024; 208 doi: 10.1016/j.phrs.2024.107375
|
| 222 |
Xuan Shen, Wenxing Zheng, Xinna Du, Yuping Chen, Xianping song, Liucai Yang, Qi Yuan. The role of C5aR1-mediated hepatic macrophage efferocytosis in NASH. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-68207-y
|
| 223 |
Genetics of nonalcoholic fatty liver disease in Asian populations. Journal of Genetics 2019; 98(1) doi: 10.1007/s12041-019-1071-8
|
| 224 |
Hyejeong Jwa, Youngshim Choi, Ui-Hyun Park, Soo-Jong Um, Seung Kew Yoon, Taesun Park. Piperine, an LXRα antagonist, protects against hepatic steatosis and improves insulin signaling in mice fed a high-fat diet. Biochemical Pharmacology 2012; 84(11) doi: 10.1016/j.bcp.2012.09.009
|
| 225 |
Yoshihiro Kamada, Hideki Fujii, Hironobu Fujii, Yoshiyuki Sawai, Yoshinori Doi, Naofumi Uozumi, Kayo Mizutani, Maaya Akita, Motoya Sato, Sachiho Kida, Noriaki Kinoshita, Nobuhiro Maruyama, Takayuki Yakushijin, Masanori Miyazaki, Hisao Ezaki, Naoki Hiramatsu, Yuichi Yoshida, Shinichi Kiso, Yasuharu Imai, Norifumi Kawada, Tetsuo Takehara, Eiji Miyoshi. Serum Mac‐2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis. PROTEOMICS – Clinical Applications 2013; 7(9-10) doi: 10.1002/prca.201200137
|
| 226 |
Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Eugeniusz Tarasów, Małgorzata Wojtkowska, Irena Białokoz-Kalinowska, Dariusz Marek Lebensztejn. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children. Canadian Journal of Gastroenterology and Hepatology 2018; 2018 doi: 10.1155/2018/3870454
|
| 227 |
Juliette Schönberg, Jürgen Borlak. miRNA biomarkers to predict risk of primary non-function of fatty allografts and drug induced acute liver failures. Molecular and Cellular Biochemistry 2025; 480(4) doi: 10.1007/s11010-024-05129-3
|
| 228 |
Rhiannon N. Hardwick, Daniel W. Ferreira, Vijay R. More, April D. Lake, Zhenqiang Lu, Jose E. Manautou, Angela L. Slitt, Nathan J. Cherrington. Altered UDP-Glucuronosyltransferase and Sulfotransferase Expression and Function during Progressive Stages of Human Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition 2013; 41(3) doi: 10.1124/dmd.112.048439
|
| 229 |
Ludovico Abenavoli, Michel Beaugrand. Transient elastography in non-alcoholic fatty liver disease. Annals of Hepatology 2012; 11(2) doi: 10.1016/S1665-2681(19)31021-X
|
| 230 |
Chong Teik Tan, Natalie Jun Hui Soh, Hao‐Chun Chang, Victor C. Yu. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities. The FEBS Journal 2023; 290(4) doi: 10.1111/febs.16317
|
| 231 |
Sara Madji, Julien Antih, Malak Tabib, Charlotte Silvestre, Anissa Ghennai, Audrey Warnery, Fabrice Vaillant, Florence Bichon, Aude Echalier, Patrick Poucheret. Extraction, Purification, Bioactivity and Pharmacological Effects of Phycobiliproteins (PBPs): A Review. Analytica 2025; 6(4) doi: 10.3390/analytica6040044
|
| 232 |
Jennie Ka Ching Lau, Xiang Zhang, Jun Yu. Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances. The Journal of Pathology 2017; 241(1) doi: 10.1002/path.4829
|
| 233 |
Peter Greaves. Histopathology of Preclinical Toxicity Studies. 2012; doi: 10.1016/B978-0-444-53856-7.00009-9
|
| 234 |
Mark Cromer, Kaitlyn Domning, Rebecca Sullivan, Mahmoud Aryan, Erin Petrie, Sujan Ravi, Mark Beasley, Mohamed Shoreibah. The risk of gastrointestinal bleeding with dual antiplatelet therapy in cirrhotics undergoing liver transplant evaluation. The American Journal of the Medical Sciences 2025; 370(6) doi: 10.1016/j.amjms.2025.09.001
|
| 235 |
Dario F. De Jesus, Kazuki Orime, Dorota Kaminska, Tomohiko Kimura, Giorgio Basile, Chih-Hao Wang, Larissa Haertle, Renzo Riemens, Natalie K. Brown, Jiang Hu, Ville Männistö, Amélia M. Silva, Ercument Dirice, Yu-Hua Tseng, Thomas Haaf, Jussi Pihlajamäki, Rohit N. Kulkarni. Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice. Journal of Clinical Investigation 2020; 130(5) doi: 10.1172/JCI127502
|
| 236 |
Margarita Papatheodoridi, Jean Baptiste Hiriart, Monica Lupsor-Platon, Fabrizio Bronte, Jerome Boursier, Omar Elshaarawy, Fabio Marra, Maja Thiele, Georgios Markakis, Audrey Payance, Edgar Brodkin, Laurent Castera, George Papatheodoridis, Aleksander Krag, Umberto Arena, Sebastian Mueller, Paul Cales, Vincenza Calvaruso, Victor de Ledinghen, Massimo Pinzani, Emmanuel A. Tsochatzis. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease. Journal of Hepatology 2021; 74(5) doi: 10.1016/j.jhep.2020.11.050
|
| 237 |
Margarita Papatheodoridi, Victor De Ledinghen, Monica Lupsor-Platon, Fabrizio Bronte, Jerome Boursier, Omar Elshaarawy, Fabio Marra, Maja Thiele, Georgios Markakis, Audrey Payance, Edgar Brodkin, Laurent Castera, George Papatheodoridis, Aleksander Krag, Umberto Arena, Sebastian Mueller, Paul Cales, Vincenza Calvaruso, Adele Delamarre, Massimo Pinzani, Emmanuel A. Tsochatzis. Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms. Journal of Hepatology 2024; 81(4) doi: 10.1016/j.jhep.2024.05.021
|
| 238 |
Yoshihiro Kamada, Eiji Miyoshi. Mac-2 Binding Protein is a Useful Liver Fibrosis Biomarker for NAFLD/NASH. Trends in Glycoscience and Glycotechnology 2017; 29(170) doi: 10.4052/tigg.1714.1E
|
| 239 |
Benjamin Rivière, Audrey Jaussent, Valérie Macioce, Stéphanie Faure, Nicolas Builles, Patrick Lefebvre, Philippe Géraud, Marie-Christine Picot, Sandra Rebuffat, Eric Renard, Valérie Paradis, Marie-Dominique Servais, Nathalie de Preville, David Nocca, Anne-Dominique Lajoix, Georges-Philippe Pageaux, Florence Galtier. The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients. Diabetes & Metabolism 2022; 48(4) doi: 10.1016/j.diabet.2022.101345
|
| 240 |
Daniella Braz Parente, Rosana Souza Rodrigues, Fernando Fernandes Paiva, Jaime Araújo Oliveira Neto, Lilian Machado-Silva, Valeria Lanzoni, Carlos Frederico Ferreira Campos, Antonio Luis Eiras-Araujo, Pedro Emmanuel Alvarenga Americano do Brasil, Philippe Garteiser, Marilia de Brito Gomes, Renata de Mello Perez, Ferruccio Bonino. Is MR Spectroscopy Really the Best MR-Based Method for the Evaluation of Fatty Liver in Diabetic Patients in Clinical Practice?. PLoS ONE 2014; 9(11) doi: 10.1371/journal.pone.0112574
|
| 241 |
Claudia Della Corte, Antonella Mosca, Andrea Vania, Arianna Alterio, Salvatore Iasevoli, Valerio Nobili. Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. Nutrition 2017; doi: 10.1016/j.nut.2017.02.008
|
| 242 |
Paulo Reis-Júnior, Ryan Tanigawa, Gustavo Heluani Antunes de Mesquita, Natalia Basan, Venâncio Alves, Luiz Augusto Carneiro D'Albuquerque, Wellington Andraus. Steatosis and steatohepatitis found in adults after death due to non-burn trauma. Clinics 2019; 74 doi: 10.6061/clinics/2019/e1070
|
| 243 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1) doi: 10.2174/1574885518666230417111247
|
| 244 |
Michael J.J. Chu, Ryash Vather, Anthony J.R. Hickey, Anthony R.J. Phillips, Adam S.J.R. Bartlett. Impact of ischaemic preconditioning on experimental steatotic livers following hepatic ischaemia–reperfusion injury: a systematic review. HPB 2015; 17(1) doi: 10.1111/hpb.12258
|
| 245 |
Erica Jennison, Christopher D. Byrne. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 2021; 27(1) doi: 10.3350/cmh.2020.0129
|
| 246 |
Jonna Weisell, Anna-Kaisa Ruotsalainen, Juha Näpänkangas, Matti Jauhiainen, Jaana Rysä. Menaquinone 4 increases plasma lipid levels in hypercholesterolemic mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82724-0
|
| 247 |
Mercedes Vazquez-Chantada, Aintzane Gonzalez-Lahera, Ibon Martinez-Arranz, Carmelo Garcia-Monzon, Manuela M. Regueiro, Juan L. Garcia-Rodriguez, Karin A. Schlangen, Iñaki Mendibil, Naiara Rodriguez-Ezpeleta, Juan J. Lozano, Karina Banasik, Johanne M. Justesen, Torben Joergensen, Daniel R. Witte, Torsten Lauritzen, Torben Hansen, Oluf Pedersen, Nicolas Veyrie, Karine Clement, Joan Tordjman, Albert Tran, Yannik Le Marchand-Brustel, Xabier Buque, Patricia Aspichueta, Jose J. Echevarria-Uraga, Antonio Martin-Duce, Joan Caballeria, Philippe Gual, Azucena Castro, Jose M. Mato, Maria L. Martinez-Chantar, Ana M. Aransay. Solute Carrier Family 2 Member 1 Is Involved in the Development of Nonalcoholic Fatty Liver Disease. Hepatology 2013; 57(2) doi: 10.1002/hep.26052
|
| 248 |
Marlies Bekaert, D. Margriet Ouwens, Tina Hörbelt, Frederique Van de Velde, Pia Fahlbusch, Daniella Herzfeld de Wiza, Yves Van Nieuwenhove, Patrick Calders, Marleen Praet, Anne Hoorens, Anja Geerts, Xavier Verhelst, Jean‐Marc Kaufman, Bruno Lapauw. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity. Obesity 2016; 24(12) doi: 10.1002/oby.21674
|
| 249 |
Yang Yu, Jeon Woong Kang, Zhi Yang Tam, Shuo Yu Xu, Eliza Li Shan Fong, Surya Pratap Singh, Ziwei Song, Lisa Tucker Kellogg, Peter So, Hanry Yu, Jie Yan, J. Quincy Brown, Ton G. van Leeuwen. A classification model for non-alcoholic steatohepatitis (NASH) using confocal Raman micro-spectroscopy. Clinical and Preclinical Optical Diagnostics 2017; doi: 10.1117/12.2281445
|
| 250 |
Andrew J. Krentz, Pierre Bedossa. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; doi: 10.1007/978-3-030-11748-1_10
|
| 251 |
Christoph Grander, Felix Grabherr, Herbert Tilg. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovascular Research 2023; 119(9) doi: 10.1093/cvr/cvad095
|
| 252 |
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz. El Hígado graso (parte 2): enfoque clínico y tratamiento. Revista colombiana de Gastroenterología 2023; 38(1) doi: 10.22516/25007440.979
|
| 253 |
Azza S. M. Awad, Ekram N. Abd Al Haleem, Wesam M. El-Bakly, Mohie A. Sherief. Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(4) doi: 10.1007/s00210-015-1207-1
|
| 254 |
Hideki Kumagai, Nobuyuki Taniguchi, Koji Yokoyama, Kimito Katsuyama, Hiroaki Yamamoto, Shoji Hara, Norio Hirota, Kouichi Itoh, Takanori Yamagata. The Speed of Sound in Rat Liver With Steatohepatitis: Ex Vivo Analysis Using Two Types of Ultrasound Systems. Ultrasound in Medicine & Biology 2019; 45(8) doi: 10.1016/j.ultrasmedbio.2019.05.004
|
| 255 |
Mengyan Wang, Tingmiao Wu, Jia Liu, Huaiping Yuan, Xiao Wang, Scott B. Reeder, Diego Hernando, Changqing Wang. Hepatic Steatosis Decreases Diffusion Parameters in Diffusion‐Weighted Imaging With Monte Carlo Simulation and Phantom Studies. Magnetic Resonance in Medicine 2026; 96(2) doi: 10.1002/mrm.70382
|
| 256 |
Thierry Lefebvre, Léonie Petitclerc, Mélanie Hébert, Laurent Bilodeau, Giada Sebastiani, Damien Olivié, Zu‐Hua Gao, Marie‐Pierre Sylvestre, Guy Cloutier, Bich N. Nguyen, Guillaume Gilbert, An Tang. MRI cine‐tagging of cardiac‐induced motion for noninvasive staging of liver fibrosis. Journal of Magnetic Resonance Imaging 2020; 51(5) doi: 10.1002/jmri.26935
|
| 257 |
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Artificial intelligence and deep learning: New tools for histopathological diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Computational and Structural Biotechnology Journal 2023; 21 doi: 10.1016/j.csbj.2023.03.048
|
| 258 |
Ellen Callewaert, Jochem Louisse, Nynke Kramer, Julen Sanz-Serrano, Mathieu Vinken. Computational Toxicology. Methods in Molecular Biology 2025; 2834 doi: 10.1007/978-1-0716-4003-6_12
|
| 259 |
Bita V. Naini, Samuel W. French. Practical Atlas of Transplant Pathology. 2016; doi: 10.1007/978-3-319-23054-2_5
|
| 260 |
Yi Jiang, Salil Chowdhury, Bing-Hong Xu, Mohamad Aghaie Meybodi, Konstantinos Damiris, Samanthika Devalaraju, Nikolaos Pyrsopoulos. Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for <i>Clostridioides difficile</i> infection. World Journal of Hepatology 2021; 13(11): 1777-1790 doi: 10.4254/wjh.v13.i11.1777
|
| 261 |
Jihane N. Benhammou, Arthur Ko, Marcus Alvarez, Minna U. Kaikkonen, Carl Rankin, Kristina M. Garske, David Padua, Yash Bhagat, Dorota Kaminska, Vesa Kärjä, Jussi Pihlajamäki, Joseph R. Pisegna, Päivi Pajukanta. Novel Lipid Long Intervening Noncoding RNA, Oligodendrocyte Maturation‐Associated Long Intergenic Noncoding RNA, Regulates the Liver Steatosis Gene Stearoyl‐Coenzyme A Desaturase As an Enhancer RNA. Hepatology Communications 2019; 3(10) doi: 10.1002/hep4.1413
|
| 262 |
Cyrielle Caussy, Meera Soni, Jeffrey Cui, Ricki Bettencourt, Nicholas Schork, Chi-Hua Chen, Mahdi Al Ikhwan, Shirin Bassirian, Sandra Cepin, Monica P. Gonzalez, Michel Mendler, Yuko Kono, Irine Vodkin, Kristin Mekeel, Jeffrey Haldorson, Alan Hemming, Barbara Andrews, Joanie Salotti, Lisa Richards, David A. Brenner, Claude B. Sirlin, Rohit Loomba. Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis. Journal of Clinical Investigation 2017; 127(7) doi: 10.1172/JCI93465
|
| 263 |
Mario Masarone, Valerio Rosato, Andrea Aglitti, Tommaso Bucci, Rosa Caruso, Teresa Salvatore, Ferdinando Carlo Sasso, Marie Francoise Tripodi, Marcello Persico, Patricia Aspichueta. Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. PLOS ONE 2017; 12(6) doi: 10.1371/journal.pone.0178473
|
| 264 |
Joanna Betlejewska, Joanna Hubska, Zuzanna Roszkowska, Aleksandra Maciejczyk, Dominika Bachurska, Jan Domański, Maciej Miarka, Joanna Raszeja-Wyszomirska, Małgorzata Bobrowicz, Urszula Ambroziak. Endocrine Disorders and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review. Biomedicines 2025; 13(10) doi: 10.3390/biomedicines13102500
|
| 265 |
Sara Karjoo. Is There an Association of Vascular Disease and Atherosclerosis in Children and Adolescents With Obesity and Non-alcoholic Fatty Liver Disease?. Frontiers in Pediatrics 2018; 6 doi: 10.3389/fped.2018.00345
|
| 266 |
Laura Giuseppina Di Pasqua, Marta Cagna, Clarissa Berardo, Mariapia Vairetti, Andrea Ferrigno. Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update. Biomedicines 2022; 10(1) doi: 10.3390/biomedicines10010194
|
| 267 |
Sandy Feng, Jennifer C. Lai. Expanded Criteria Donors. Clinics in Liver Disease 2014; 18(3) doi: 10.1016/j.cld.2014.05.005
|
| 268 |
Antonio Orlacchio, Francesca Bolacchi, Marco Antonicoli, Irene Coco, Elisa Costanzo, Daniela Tosti, Simona Francioso, Mario Angelico, Giovanni Simonetti. Liver Elasticity in NASH Patients Evaluated with Real-Time Elastography (RTE). Ultrasound in Medicine & Biology 2012; 38(4) doi: 10.1016/j.ultrasmedbio.2011.12.023
|
| 269 |
Shailendra Arindkar, Jashdeep Bhattacharjee, Jerald Mahesh Kumar, Barun Das, Pramod Upadhyay, Shajahan Asif, Ramesh C Juyal, Subeer S Majumdar, Nagarajan Perumal. Antigen peptide transporter 1 is involved in the development of fructose‐induced hepatic steatosis in mice. Journal of Gastroenterology and Hepatology 2013; 28(8) doi: 10.1111/jgh.12186
|
| 270 |
Mônica Rodrigues de Araújo Souza, Margareth de Fátima Formiga de Melo Diniz, José Eymard Moraes de Medeiros-Filho, Maria Salete Trigueiro de Araújo. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arquivos de Gastroenterologia 2012; 49(1) doi: 10.1590/S0004-28032012000100015
|
| 271 |
Victoria Sid, Yaw L. Siow, Karmin O. Role of folate in nonalcoholic fatty liver disease. Canadian Journal of Physiology and Pharmacology 2017; 95(10) doi: 10.1139/cjpp-2016-0681
|
| 272 |
Milena Vesković, Milica Labudović-Borović, Ivan Zaletel, Jelena Rakočević, Dušan Mladenović, Bojan Jorgačević, Danijela Vučević, Tatjana Radosavljević. The Effects of Betaine on the Nuclear Fractal Dimension, Chromatin Texture, and Proliferative Activity in Hepatocytes in Mouse Model of Nonalcoholic Fatty Liver Disease. Microscopy and Microanalysis 2018; 24(2) doi: 10.1017/S1431927617012806
|
| 273 |
Lin Ding, Jun-Lin Liu, Waseem Hassan, Lu-Lu Wang, Fang-Rong Yan, Jing Shang. Lipid modulatory activities of Cichorium glandulosum Boiss et Huet are mediated by multiple components within hepatocytes. Scientific Reports 2014; 4(1) doi: 10.1038/srep04715
|
| 274 |
Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Kento Imajo, Yoshio Sumida, Yuichiro Eguchi, Hideki Fujii, Hideyuki Hyogo, Masafumi Ono, Yasuaki Suzuki, Takumi Kawaguchi, Kazuaki Chayama, Saiyu Tanaka, Kazuma Fujimoto, Keizo Anzai, Toshiji Saibara, Michio Sata, Yoshito Itoh, Atsushi Nakajima, Takeshi Okanoue; Japan Study Group of NAFLD (JSG-NAFLD). Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(29): 10108-10114 doi: 10.3748/wjg.v20.i29.10108
|
| 275 |
Shelly Kakar, Mohannad Dugum, Ricardo Cabello, Abhinav Humar, Jawad Ahmad, Shahid M. Malik. Incidence of Recurrent NASH-Related Allograft Cirrhosis. Digestive Diseases and Sciences 2019; 64(5) doi: 10.1007/s10620-018-5413-9
|
| 276 |
Neeta B. Amin, Santos Carvajal-Gonzalez, Julie Purkal, Tong Zhu, Collin Crowley, Sylvie Perez, Kristin Chidsey, Albert M. Kim, Bryan Goodwin. Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis. Science Translational Medicine 2019; 11(520) doi: 10.1126/scitranslmed.aav9701
|
| 277 |
Chung Eun Lee. Effects of Intermittent Fasting on Splenic Galectin-3 Protein Expression in High-fat Diet-fed Mice. Anatomy & Biological Anthropology 2023; 36(4) doi: 10.11637/aba.2023.36.4.209
|
| 278 |
Masato Yoneda, Kento Imajo, Yuichiro Eguchi, Hideki Fujii, Yoshio Sumida, Hideyuki Hyogo, Masafumi Ono, Yasuaki Suzuki, Takumi Kawaguchi, Noriaki Aoki, Michio Sata, Kazuyuki Kanemasa, Yutaka Kohgo, Toshiji Saibara, Kazuaki Chayama, Yoshito Itoh, Toshikazu Yoshikawa, Keizo Anzai, Kazuma Fujimoto, Takeshi Okanoue, Atsushi Nakajima. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. Journal of Gastroenterology 2013; 48(9) doi: 10.1007/s00535-012-0704-y
|
| 279 |
Eiji Miyoshi, Yoshihiro Kamada. Application of glycoscience to the early detection of pancreatic cancer. Cancer Science 2016; 107(10) doi: 10.1111/cas.13011
|
| 280 |
Angela C Cheung, Brian D Juran, Erik M Schlicht, Bryan M McCauley, Elizabeth J Atkinson, Raymond Moore, Julie K Heimbach, Kymberly D Watt, Tsung-Teh Wu, Nicholas F LaRusso, Gregory J Gores, Zhifu Sun, Konstantinos N Lazaridis. DNA Methylation Profile of Liver Tissue in End-Stage Cholestatic Liver Disease. Epigenomics 2022; 14(8) doi: 10.2217/epi-2021-0343
|
| 281 |
Lei Wu, Xiaomeng Guo, Yao Niu, Siyu Li, Shiyu Jiang, Xinyuan Wang, Yukang Gao, Shan Zhang, Litao Zhou, Lingdan Yang, Zian Gao, Yuqing Yang. Mao Jian Black Tea Ethanol Extract Alleviates Alcoholic Liver Injury in Mice via Regulation of the PI3K/Akt/NF-κB Signaling Pathway. Foods 2025; 14(20) doi: 10.3390/foods14203492
|
| 282 |
Michael J. J. Chu, Anthony J. R. Hickey, Anthony R. J. Phillips, Adam S. J. R. Bartlett. The Impact of Hepatic Steatosis on Hepatic Ischemia-Reperfusion Injury in Experimental Studies: A Systematic Review. BioMed Research International 2013; 2013 doi: 10.1155/2013/192029
|
| 283 |
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
|
| 284 |
Junling Wang, Ping Li, Zhilong Jiang, Qiuhui Yang, Yuqiang Mi, Yonggang Liu, Ruifang Shi, Yonghe Zhou, Jinsheng Wang, Wei Lu, Si Li, Dan Liu. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD. The Korean Journal of Internal Medicine 2016; 31(3) doi: 10.3904/kjim.2015.253
|
| 285 |
Gaspard d'Assignies, Cindy Fayard, Helena Leitao, Toni Alfaiate, Florence Tubach, Safi Dokmak, Valérie Paradis, Bernard E. Van Beers, Maxime Ronot, Valérie Vilgrain. Liver steatosis assessed by preoperative MRI: An independent risk factor for severe complications after major hepatic resection. Surgery 2016; 159(4) doi: 10.1016/j.surg.2015.10.008
|
| 286 |
Daniella Braz Parente, Hugo Perazzo, Fernando Fernandes Paiva, Carlos Frederico Ferreira Campos, Carlos José Saboya, Silvia Elaine Pereira, Felipe d’Almeida e Silva, Rosana Souza Rodrigues, Renata de Mello Perez. Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71723-2
|
| 287 |
Raj Vuppalanchi, Marshall E. McCabe, Sweta R. Tandra, Siva P. Parcha, Adil Ghafoor, Leslie Schuh, Margaret M. Inman, Don J. Selzer, Dimitrios Stefanidis, Naga Chalasani. Safety and Efficacy of Bariatric Surgery in Cirrhosis Patients With Extreme Obesity. Annals of Surgery 2022; 275(1) doi: 10.1097/SLA.0000000000003891
|
| 288 |
Ayako Suzuki, Anna Mae Diehl. Nonalcoholic Steatohepatitis. Annual Review of Medicine 2017; 68(1) doi: 10.1146/annurev-med-051215-031109
|
| 289 |
Olivier Govaere, Quentin M. Anstee. Encyclopedia of Cell Biology. 2023; doi: 10.1016/B978-0-12-821618-7.00265-0
|
| 290 |
B. Claire McDyre, Mohamed Diwan M. AbdulHameed, Matthew G. Permenter, William E. Dennis, Christine E. Baer, Jason M. Koontz, Molly H. Boyle, Anders Wallqvist, John A. Lewis, Danielle L. Ippolito. Comparative Proteomic Analysis of Liver Steatosis and Fibrosis after Oral Hepatotoxicant Administration in Sprague-Dawley Rats. Toxicologic Pathology 2018; 46(2) doi: 10.1177/0192623317747549
|
| 291 |
F. Wipfli, M. A. Lone, A. von Eckardstein, A. Verrijken, S. Francque, J. Weyler, L. Van Gaal, B. Staels, T. Hornemann. Increased 1-deoxysphingolipids caused by an altered plasma alanine to serine ratio are associated with metabolic dysfunction-associated steatotic liver disease (MASLD). Metabolomics 2025; 21(6) doi: 10.1007/s11306-025-02359-4
|
| 292 |
Anita Lal, Jacqueline L. Parai, Christopher M. Milroy. Liver Pathology in First Presentation Diabetic Ketoacidosis at Autopsy. Academic Forensic Pathology 2016; 6(2) doi: 10.23907/2016.028
|
| 293 |
Keith C. Summa, Robin M. Voigt, Christopher B. Forsyth, Maliha Shaikh, Kate Cavanaugh, Yueming Tang, Martha Hotz Vitaterna, Shiwen Song, Fred W. Turek, Ali Keshavarzian, David L. Boone. Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation. PLoS ONE 2013; 8(6) doi: 10.1371/journal.pone.0067102
|
| 294 |
Silvia Gaia, Daniela Campion, Andrea Evangelista, Maurizio Spandre, Loretta Cosso, Franco Brunello, Giovannino Ciccone, Elisabetta Bugianesi, Mario Rizzetto. Non‐invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data. Liver International 2015; 35(8) doi: 10.1111/liv.12761
|
| 295 |
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in mice. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
|
| 296 |
C. Venturi, C. Sempoux, J. Bueno, J.C. Ferreres Pinas, C. Bourdeaux, J. Abarca-Quinones, J. Rahier, R. Reding. Novel Histologic Scoring System for Long-Term Allograft Fibrosis After Liver Transplantation in Children. American Journal of Transplantation 2012; 12(11) doi: 10.1111/j.1600-6143.2012.04210.x
|
| 297 |
Consolato M. Sergi, Mohit Kehar, Carolina Jimenez-Rivera. Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol. Therapeutic Advances in Endocrinology and Metabolism 2024; 15 doi: 10.1177/20420188241227766
|
| 298 |
Dipali Sharma, Neeraj K. Saxena. Murine Models, Energy Balance, and Cancer. Energy Balance and Cancer 2015; 10 doi: 10.1007/978-3-319-16733-6_12
|
| 299 |
Valerio Nobili, Anna Alisi, Kimberly P. Newton, Jeffrey B. Schwimmer. Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2016; 150(8) doi: 10.1053/j.gastro.2016.03.009
|
| 300 |
Zita Galvin, Ramraj Rajakumar, Emily Chen, Oyedele Adeyi, Markus Selzner, David Grant, Gonzalo Sapisochin, Paul Greig, Mark Cattral, Ian McGilvray, Anand Ghanekar, Nazia Selzner, Les Lilly, Keyur Patel, Mamatha Bhat. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. Liver Transplantation 2019; 25(1) doi: 10.1002/lt.25338
|
| 301 |
Sa’ed H. Zyoud, Samer O. Alalalmeh, Omar E. Hegazi, Muna Shakhshir, Faris Abushamma, Samah W. Al-Jabi. An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysis. Gut Pathogens 2024; 16(1) doi: 10.1186/s13099-024-00624-w
|
| 302 |
Karima Begriche, Julie Massart, Marie-Anne Robin, Fabrice Bonnet, Bernard Fromenty. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 2013; 58(4) doi: 10.1002/hep.26226
|
| 303 |
Riccardo Righetti, Felice Cinque, Keyur Patel, Giada Sebastiani. The role of noninvasive biomarkers for monitoring cell injury in advanced liver fibrosis. Expert Review of Gastroenterology & Hepatology 2025; 19(1) doi: 10.1080/17474124.2025.2450717
|
| 304 |
Fatih Eren, Ramazan Kurt, Fatih Ermis, Ozlen Atug, Nese Imeryuz, Yusuf Yilmaz. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease. Clinical Biochemistry 2012; 45(9) doi: 10.1016/j.clinbiochem.2012.03.019
|
| 305 |
Devy Maulidya Cahyani, Andang Miatmoko, Berlian Sarasitha Hariawan, Kusuma Eko Purwantari, Retno Sari. N-nitrosodiethylamine induces inflammation of liver in mice. Journal of Basic and Clinical Physiology and Pharmacology 2021; 32(4) doi: 10.1515/jbcpp-2020-0475
|
| 306 |
Hanxiang Zhong. Non-alcoholic fatty liver disease: pathogenesis and models. American Journal of Translational Research 2024; 16(2) doi: 10.62347/KMSA5983
|
| 307 |
Roxana Liana Lucaciu, Sorina Cezara Coste, Adriana Corina Hangan, Mihaela Iancu, Olga Hilda Orășan, Angela Cozma, Sidonia Gog Bogdan, Lucia Maria Procopciuc. Pathogenesis and Clinical Management of Metabolic Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2025; 26(12) doi: 10.3390/ijms26125717
|
| 308 |
Kyung Eun Kim, Hyun Joo Shin, Yeajin Ju, Youngae Jung, Hyeong Seok An, So Jeong Lee, Eun Ae Jeong, Jaewoong Lee, Geum-Sook Hwang, Gu Seob Roh. Intermittent Fasting Attenuates Metabolic-Dysfunction-Associated Steatohepatitis by Enhancing the Hepatic Autophagy–Lysosome Pathway. Nutrients 2023; 15(21) doi: 10.3390/nu15214574
|
| 309 |
Robin C. Su, Apurva Lad, Joshua D. Breidenbach, Thomas M. Blomquist, William T. Gunning, Prabhatchandra Dube, Andrew L. Kleinhenz, Deepak Malhotra, Steven T. Haller, David J. Kennedy, Luca Vanella. Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD). PLOS ONE 2019; 14(12) doi: 10.1371/journal.pone.0225604
|
| 310 |
Neeta B. Amin, Aditi R. Saxena, Veena Somayaji, Robert Dullea. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology. Clinical Therapeutics 2023; 45(1) doi: 10.1016/j.clinthera.2022.12.008
|
| 311 |
Mustapha Najimi, Sébastien Michel, Maria M. Binda, Kris Gellynck, Nathalie Belmonte, Giuseppe Mazza, Noelia Gordillo, Yelena Vainilovich, Etienne Sokal. Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model. Cells 2022; 11(18) doi: 10.3390/cells11182854
|
| 312 |
Noam Peleg, Assaf Issachar, Orly Sneh-Arbib, Amir Shlomai. AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. Digestive and Liver Disease 2017; 49(10) doi: 10.1016/j.dld.2017.05.002
|
| 313 |
Mona A. Elhosary, Mohammed Bahey-El-Din, Amany AbdelBary, Nadia El Guink, Hamida M. Aboushleib. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model. Microbial Pathogenesis 2019; 131 doi: 10.1016/j.micpath.2019.04.014
|
| 314 |
Stephanie Breher-Esch, Nishika Sahini, Anna Trincone, Christin Wallstab, Jürgen Borlak. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease. BMC Medical Genomics 2018; 11(1) doi: 10.1186/s12920-018-0438-7
|
| 315 |
Mariana Perez-Robles, Wendy Campos-Perez, Juan José Rivera-Valdés, Ramón Antonio Franco-Topete, Eduardo Miguel Navarrete-Medina, Monserrat Maldonado-González, Bertha Ruíz-Madrigal, Sarai Citlalic Rodríguez-Reyes, Erika Martinez-Lopez. Elevated Serum Low-Density Lipoproteins-Cholesterol Levels and B1B2/B2B2 CETP Genotype Are Positively Associated with Nonalcoholic Fatty Liver Disease in Women with Gallstone Disease. Metabolic Syndrome and Related Disorders 2023; 21(1) doi: 10.1089/met.2022.0010
|
| 316 |
Oscar René Zambrano-Vásquez, Fernando Cortes-Camacho, Juan Carlos Cabrera-Angeles, Ana Lilia Hernández-Alba, Fernando Enrique García-Arroyo, Jorge Ismael Castañeda-Sánchez, Elena Aréchaga-Ocampo, Omar Emiliano Aparicio-Trejo, Leonardo Del Valle-Mondragón, Constanza Estefanía Martínez-Olivares, Rogelio Hernández-Pando, Laura Gabriela Sánchez-Lozada, Horacio Osorio-Alonso. The Combination Empagliflozin/Metformin Attenuates the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease in a Diet-Induced Experimental Rat Model. International Journal of Molecular Sciences 2025; 26(18) doi: 10.3390/ijms26189010
|
| 317 |
Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, Hideki Fujii, Yoshio Sumida, Kojiroh Mori, Saiyu Tanaka, Makoto Yamada, Maaya Akita, Kayo Mizutani, Hironobu Fujii, Akiko Yamamoto, Shinji Takamatsu, Yuichi Yoshida, Yoshito Itoh, Norifumi Kawada, Kazuaki Chayama, Toshiji Saibara, Tetsuo Takehara, Eiji Miyoshi. A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. Hepatology 2015; 62(5) doi: 10.1002/hep.28002
|
| 318 |
Yong-Jik Lee, Yoo-Na Jang, Yoon-Mi Han, Hyun-Min Kim, Jong-Min Jeong, Min Jeoung Son, Chang Bae Jin, Hyoung Ja Kim, Hong Seog Seo. Caffeoylquinic Acid-Rich Extract ofAster glehniF. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδand Adiponectin in ApoE KO Mice. PPAR Research 2017; 2017 doi: 10.1155/2017/3912567
|
| 319 |
Jihane N. Benhammou, Elizabeth S. Aby, Gayaneh Shirvanian, Kohlett Manansala, Shehnaz K. Hussain, Myron J. Tong. Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-66507-7
|
| 320 |
Anurak Bunnoy, Kanokporn Saenphet, Saisamorn Lumyong, Supap Saenphet, Siriwadee Chomdej. Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic rats. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0624-5
|
| 321 |
Kristina Önnerhag, Peter M. Nilsson, Stefan Lindgren. Insulin resistance with impaired fasting glucose increases the risk of NAFLD. Open Journal of Gastroenterology 2013; 3(03) doi: 10.4236/ojgas.2013.33028
|
| 322 |
M Giannetti, P Piaggi, G Ceccarini, S Mazzeo, G Querci, P Fierabracci, G Salvetti, G Galli, I Ricco, S Martinelli, C Di Salvo, M Anselmino, A Landi, P Vitti, A Pinchera, F Santini. Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding. International Journal of Obesity 2012; 36(3) doi: 10.1038/ijo.2011.243
|
| 323 |
Nadia F. Hassan, Gehan M. Soliman, Ebtsam F. Okasha, Amany M. Shalaby. Histological, Immunohistochemical and Biochemical Study of Experimentally Induced Fatty Liver in Adult Male Albino Rat and the Possible Protective Role of Pomegranate. Journal of Microscopy and Ultrastructure 2017; doi: 10.1016/j.jmau.2017.04.001
|
| 324 |
Maria Lilibeth Manzanilla Valdez, Maira Rubi Segura Campos. Renal and Hepatic Disease:Cnidoscolus aconitifoliusas Diet Therapy Proposal for Prevention and Treatment. Journal of the American College of Nutrition 2021; 40(7) doi: 10.1080/07315724.2020.1810171
|
| 325 |
Maddi Oses, María Medrano, Arkaitz Galbete, Lide Arenaza, Jonatan R. Ruiz, Felix Sánchez‐Valverde, Francisco B. Ortega, Idoia Labayen. A sociodemographic, anthropometric and lifestyle‐based prediction score for screening children with overweight and obesity for hepatic steatosis: The HEPAKID index. Pediatric Obesity 2021; 16(8) doi: 10.1111/ijpo.12770
|
| 326 |
Yasuyuki Shigematsu, Hiroaki Kanda, Gulanbar Amori, Yu Takahashi, Yutaka Takazawa, Kentaro Inamura. Nonalcoholic non-virus-related hepatocellular carcinoma arising from nonsteatotic liver. Medicine 2022; 101(5) doi: 10.1097/MD.0000000000028746
|
| 327 |
Oskar Knittelfelder, Sofia Traikov, Olga Vvedenskaya, Andrea Schuhmann, Sandra Segeletz, Anna Shevchenko, Andrej Shevchenko. Shotgun Lipidomics Combined with Laser Capture Microdissection: A Tool To Analyze Histological Zones in Cryosections of Tissues. Analytical Chemistry 2018; 90(16) doi: 10.1021/acs.analchem.8b02004
|
| 328 |
Seonghwan Hwang, Hwayoung Yun, Sungwon Moon, Ye Eun Cho, Bin Gao. Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.751802
|